Introduction {#s1}
============

With 1.7 million deaths from tuberculosis in 2016, *Mycobacterium tuberculosis* continues to have a significant impact on world health ([@bib54]). For *M. tuberculosis* to cause disease, the bacillus must export effector proteins to the host-pathogen interface. These effectors enable *M. tuberculosis* to grow in macrophages and avoid clearance by the host immune response ([@bib2]). At least some of these effectors are exported by *M. tuberculosis* via the specialized SecA2 export pathway ([@bib45]).

The mechanism of SecA2 export remains poorly understood. SecA2 is a paralog of the SecA ATPase of the general Sec protein export pathway. The general Sec pathway transports preproteins with N-terminal signal sequences across the inner membrane through a channel comprised of SecY, SecE and SecG proteins ([@bib9]). Preproteins must be in an unfolded state to travel through the SecYEG channel and, in Gram-negative bacteria, the SecB chaperone binds a subset of preproteins to maintain them in an unfolded translocation competent state. Following export across the membrane, the signal sequence is cleaved and the mature protein is released ([@bib48]). While all bacteria possess an essential Sec pathway that carries out the majority of protein export, only mycobacteria and a subset of Gram-positive bacteria possess specialized Sec export systems that are defined by a second SecA ([@bib4]; [@bib31]). In these organisms, SecA1 is the name given to the canonical SecA and the specialized SecA is named SecA2. For the mycobacterial SecA2 system, the housekeeping SecYEG channel, and possibly SecA1, as well, are also involved ([@bib27]; [@bib36]). However, SecA1 and SecA2 are functionally distinct, as shown by their inability to compensate for the loss of one another ([@bib8]; [@bib40]), and it remains unclear how SecA2 functions to export its relatively small and specific subset of proteins.

Here, we carried out a suppressor screen using a dominant negative *secA2 K129R* mutant of *Mycobacterium smegmatis*, a fast-growing model mycobacteria, as a means to identify new components of the mycobacterial SecA2 pathway. The K129R substitution is in the ATP binding site of SecA2, and past studies lead to a model where SecA2 K129R is defective for SecA2-dependent export but still able to interact with its normal binding partners that include SecYEG ([@bib40]; [@bib27]). As a result, SecA2 K129R disrupts SecYEG channels at the membrane, which hinders both general Sec and specialized SecA2 export as evidenced by more severe phenotypes of *secA2 K129R* than a Δ*secA2* null mutation ([@bib27]). A large collection of *secA2 K129R* suppressor mutations mapped to *msmeg_1684*, a gene of unknown function that we renamed *satS* for [S]{.ul}ec[A]{.ul}2 ([t]{.ul}wo) [S]{.ul}uppressor. SatS is also present in *M. tuberculosis* and, remarkably, the *M. tuberculosis satS* gene is in an operon with the gene encoding SapM, which is a secreted phosphatase exported by the SecA2 pathway ([@bib57]).

Here, we demonstrated that SatS, which we revealed is required for *M. tuberculosis* growth in macrophages, functions in the export of SapM and an additional subset of the proteins exported by the SecA2 pathway. We further identified properties of SatS that indicate a function as a protein export chaperone that protects its substrates from inappropriate interactions in the cytoplasm and additionally assists in their export. Finally, we determined the structure of the C-domain of SatS (SatS~C~), which reveals a new fold lacking similarities to any solved chaperone structures, yet contains surface hydrophobic grooves resembling those of the SecB chaperone. The identification of SatS expands our understanding of SecA2 export in mycobacteria and provides another example of the diversity of molecular chaperones across biological systems.

Results {#s2}
=======

*satS* suppressors of *secA2 K129R* {#s2-1}
-----------------------------------

A *secA2 K129R* mutant of *M. smegmatis* exhibits more exacerbated phenotypes (*i.e.* azide sensitivity and poor growth on Mueller-Hinton agar) than a Δ*secA2* deletion mutant ([@bib27]) ([Figure 1A](#fig1){ref-type="fig"}). Starting with cultures of ∆*secA2* expressing the *secA2 K129R* allele on an integrating plasmid (this strain is referred to as *secA2 K129R* from hereon), we collected spontaneous suppressor mutants that restored growth on Mueller-Hinton agar. Whole-genome sequencing of six extragenic suppressors revealed mutations in the same gene *msmeg_1684* ([Figure 1B](#fig1){ref-type="fig"}). Three additional suppressors with mutations in *msmeg_1684* were identified by directly sequencing the *msmeg_1684* gene and upstream sequence in our pool of suppressors ([Figure 1B](#fig1){ref-type="fig"}). Msmeg_1684 is a highly acidic protein (pI 3.83) of unknown function with conserved homologs in all mycobacterial species, as well as other actinomycetes ([@bib29]). However, no homologous proteins exist outside of actinomycetes and Msmeg_1684 does not have any conserved domains to predict function. Henceforth, we refer to *msmeg_1684* as *satS* (*[s]{.ul}ec[A]{.ul}2* ([t]{.ul}wo) [s]{.ul}uppressor).

![∆*satS* mutant suppresses SecA2 K129R phenotypes.\
(**A**) Mueller-Hinton growth phenotypes and azide sensitivity of *M. smegmatis* ∆*secA2* mutant expressing wild-type *secA2* (∆*secA2 +psecA2*), an empty vector, or *secA2 K129R* (*secA2 K129R*), and two representative suppressors. (**B**) Nine suppressor mutations affected *satS* (*msmeg_1684*). Red stars indicate approximate locations of mutations. For panels C, D, E and F, wild-type *M. smegmatis mc^2^155*, ∆*secA2*, *secA2 K129R,* ∆*satS/secA2 K129R*, and ∆*satS/secA2 K129R* complemented with *satS~Msm~* or *satS~Mtb~* were used. (**C**) Mueller-Hinton growth phenotypes and azide sensitivity of the strains described above. (**D**) Whole cell lysates (WCL), subcellular envelope (ENV) and soluble (SOL) fractions were separated by SDS-PAGE, and SecA2 protein was detected by Immunoblot. (**E**) Densitometry was used to quantify SecA2 levels in the soluble and envelope fractions (ImageJ). Percent localization to a given fraction for SecA2 is reported as the percentage of the total (soluble +envelope). Error bars indicate the standard error of the mean of three independent experiments. (**E**) Subcellular fractions were separated by SDS-PAGE and SecY protein was detected by Immunoblot. All results shown are representative of at least three independent experiments.](elife-40063-fig1){#fig1}

Seven of the nine suppressor mutations in *satS* were expected to be loss-of-function mutations (*i.e* frameshifts or truncations). To validate that loss of *satS* suppresses *secA2 K129R* phenotypes, we deleted *satS* in the *secA2 K129R* mutant background. For future experiments, we also constructed a ∆*satS* mutant in a *secA2*^+^ background. The ∆*satS* mutant had no in vitro growth defect compared to wild-type *M. smegmatis* mc^2^155 ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Deletion of *satS* suppressed the exacerbated phenotypes of *secA2 K129R*, and the suppression phenotype of Δ*satS* could be complemented by adding back a copy of *satS* from *M. smegmatis* ([Figure 1C](#fig1){ref-type="fig"}). Complementation was also successful with the *M. tuberculosis satS* homolog *rv3311* indicating that SatS function is conserved in *M. smegmatis* and *M. tuberculosis* ([Figure 1C](#fig1){ref-type="fig"}).

Unlike wild-type SecA2, which is predominantly in the cytoplasm, the majority of SecA2 K129R is localized to the membrane-containing cell envelope fraction, consistent with SecA2 K129R being trapped in a non-functional complex with SecYEG ([@bib40]). We assessed the ability of ∆*satS* to suppress the mislocalization of SecA2 K129R using immunoblot analysis of envelope (cell wall and membrane) and soluble (cytoplasm) fractions with SecA2 antibodies. Total SecA2 K129R levels were unchanged in the ∆*satS* background ([Figure 1D](#fig1){ref-type="fig"}). However, the absence of SatS suppressed the aberrant localization of SecA2 K129R (*i.e.* in the ∆*satS/secA2 K129R* strain) such that SecA2 K129R was now primarily localized to the cytoplasm, similar to wild-type SecA2 ([Figure 1D and E](#fig1){ref-type="fig"}). We immunoblotted for the cell wall MspA porin and the cytoplasmic GroEL protein as fractionation controls ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). SecA2 K129R is also associated with reduced levels of SecY, which is a presumed mechanism to eliminate jammed SecA2 K129R-SecYEG channels ([@bib27]). When we immunoblotted fractions from the ∆*satS/secA2 K129R* strain with SecY antibodies, we observed that the absence of SatS suppressed the SecA2 K129R effect on SecY. Both the rescued localization of SecA2 K129R and SecY levels observed in the ∆*satS* mutant could be complemented by introduction of *satS~Msm~* ([Figure 1D, E and F](#fig1){ref-type="fig"}). These results indicate that SatS is required for SecA2 K129R retention at the membrane in non-productive complexes with SecYEG. By extension, these results suggest a role for SatS in the SecA2 export pathway.

SatS is required for export of the SecA2-dependent SapM phosphatase {#s2-2}
-------------------------------------------------------------------

In *M. tuberculosis*, the gene encoding SatS is immediately downstream of the gene encoding SapM. Reverse transcriptase (RT) PCR performed on RNA from wild-type *M. tuberculosis* strain H37Rv was used to demonstrate that *sapM* and *satS* are in an operon ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). This genomic arrangement is striking as SapM, a secreted phosphatase of *M. tuberculosis* is exported by the SecA2 pathway ([@bib57]). While SapM does not have an ortholog in *M. smegmatis*, we identified 26 mycobacterial species in which the *sapM-satS* gene arrangement is conserved ([@bib51]).

We constructed a ∆*satS* mutant of *M. tuberculosis* H37Rv to test if SatS is required for SapM secretion. The ∆*satS* mutant of *M. tuberculosis* did not exhibit an in vitro growth defect ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). We monitored SapM secretion into culture media by immunoblotting culture filtrate proteins (CFPs) prepared from H37Rv, the ∆*secA2* mutant, the ∆*satS* mutant, and the ∆*satS* mutant complemented with *satS~Mtb~* using SapM antibodies. As expected, a SapM secretion defect was observed in the ∆*secA2* mutant. Even more striking was the SapM secretion defect of the ∆*satS* mutant, which was reproducibly more severe than the ∆*secA2* mutant ([Figure 2A](#fig2){ref-type="fig"}). This phenotype could be partially complemented with a *satS~Mtb~* plasmid that produced 26% of wild type levels of SatS ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 3A](#fig2s3){ref-type="fig"}). As controls, we immunoblotted the CFPs for detection of Mpt32, which is exported in a SecA2-independent manner and was not affected in the ∆*satS* mutant ([Figure 2A](#fig2){ref-type="fig"}), and also for the cytoplasmic SigA protein to rule out cell lysis contaminating the culture filtrates ([Figure 2---figure supplement 3B](#fig2s3){ref-type="fig"}). Since SapM is a phosphatase, we also quantified SapM secretion by measuring phosphatase activity in the culture filtrates, using p-Nitrophenyl Phosphate (PNPP) as a substrate. Consistent with the immunoblot data, there was significantly less phosphatase activity in the supernatant of a ∆*secA2* mutant compared to H37Rv, the ∆*satS* mutant exhibited an even more severe reduction in secreted phosphatase activity, and the ∆*satS* mutant phenotype could be complemented ([Figure 2B](#fig2){ref-type="fig"}). These results extend our identification of SatS as a SecA2 suppressor by revealing a role of SatS in the SecA2-dependent secretion of SapM by *M. tuberculosis*.

![SatS is required for the export of SapM.\
(**A**) Equal protein from culture supernatants from *M. tuberculosis* H37Rv, ∆*secA2*, ∆*satS* and the complemented strain (∆*satS +psatS~Mtb~*) were immunoblotted for SapM and Mpt32. (**B**) Phosphatase activity in triplicate culture supernatant samples was examined by quantifying cleavage of pNPP. Rates of pNPP cleavage were normalized to H37Rv. (**C**) Equal protein from culture supernatants from *M. smegmatis* mc^2^155, ∆*secA2*, ∆*satS* and the complemented strain (∆*satS +psatS~Msm~*) were examined for levels of SapM and Mpt32 by Immunoblot (**D**) Whole cell phosphatase activity assay in *M. smegmatis*. All strains are expressing SapM, SapM lacking its signal sequence (∆ss-SapM), or an empty vector as indicated. Triplicate wells containing 2 × 10^5^ cells/well were grown in a 96 well plate for 24 hr at 37°C before measuring phosphatase activity by quantifying cleavage of pNPP. Rates were normalized to mc^2^155 +SapM. (**E**) Equal protein levels from whole cell lysates prepared from the same cultures as used for panel A or (**F**) the soluble, cytoplasmic fraction of *M. tuberculosis* H37Rv, ∆*secA2*, ∆*satS* and the complemented strain (∆*satS +psatS~Mtb~*) were immunoblotted for SapM and SigA. (**G**) Equal protein levels from whole cell lysates of prepared from the same cultures as used for panel C were immunoblotted for SapM and GroEL. Densitometry of blots from three experiments was performed (ImageJ). Percent difference of the mean intensity relative to wild-type is reported below each immunoblot. All data are representative of at least three independent experiments and all error bars represent standard deviation of the mean of three independent replicates for each strain. n.s. -- no significant difference; \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001 by ANOVA and Tukey's post hoc test.](elife-40063-fig2){#fig2}

Even though *M. smegmatis* lacks a SapM orthologue, when we expressed *M. tuberculosis sapM* in *M. smegmatis*, SapM was also secreted in a SecA2 and SatS dependent manner ([Figure 2C](#fig2){ref-type="fig"}). Again, the SapM secretion defect of a ∆*satS* mutant was more severe than that of a ∆*secA2* mutant and this phenotype could be complemented ([Figure 2C](#fig2){ref-type="fig"}). As controls we immunoblotted for secreted Mpt32, which was not affected by the ∆*satS* mutation ([Figure 2C](#fig2){ref-type="fig"}), and for the cytoplasmic GroEL protein to rule out cell lysis ([Figure 2---figure supplement 3C](#fig2s3){ref-type="fig"}). This result indicates functional conservation of SatS in *M. smegmatis* and *M. tuberculosis*, and it indicates that the more amenable *M. smegmatis* is a valid model for studying SatS function.

To develop a higher throughput method for monitoring SatS and SecA2-dependent export, we established a whole cell assay for measuring secreted SapM phosphatase activity from *M. smegmatis* grown in 96 well plates. Importantly, this assay was specific for secreted SapM; it did not detect cytoplasmic SapM, as demonstrated by background levels of phosphatase activity of a *M. smegmatis* strain expressing non-exported cytoplasmic SapM lacking a signal sequence (∆ss-SapM). In contrast, *M. smegmatis* expressing full length SapM preprotein, which is secreted, exhibited significantly greater activity ([Figure 2D](#fig2){ref-type="fig"}). When the ∆*secA2* mutant and the ∆*satS* mutant were tested in this whole cell phosphatase assay, the results confirmed the immunoblot data. Secreted phosphatase activity was reduced in both ∆*satS* and ∆*secA2* mutants, and the reduction was significantly more dramatic in the *satS* mutant ([Figure 2D](#fig2){ref-type="fig"}). The reduced activity of the ∆*satS* mutant could be complemented with either SatS*~Mtb~* or SatS*~Msm~* ([Figure 2D](#fig2){ref-type="fig"}).

SatS effects on cellular levels of SapM {#s2-3}
---------------------------------------

In addition to the reduced levels of secreted SapM, the total cellular (*i.e.* in whole cell lysate) and cytoplasmic levels of SapM were dramatically reduced in the *M. tuberculosis* ∆*satS* mutant compared to H37Rv, the ∆*secA2* mutant and the complemented ∆*satS* strains ([Figure 2E and F](#fig2){ref-type="fig"}). Notably, the reduction observed in the ∆*satS* mutant differed from a modest intracellular reduction of SapM in the ∆*secA2* mutant, and was specific to SapM as the levels of SigA were comparable across strains ([Figure 2E and F](#fig2){ref-type="fig"}). The same results were obtained with SapM-expressing *M. smegmatis* strains ([Figure 2G](#fig2){ref-type="fig"}). In *M. smegmatis*, GroEL was used as a loading control and is comparable across strains ([Figure 2G](#fig2){ref-type="fig"}).

The reduced cellular and cytoplasmic levels of SapM in the ∆*satS* mutant might have reflected transcriptional or translational effects of SatS on *sapM*. Alternatively, SatS might act post-translationally to stabilize SapM prior to its export. Using quantitative Real-Time PCR (qRT-PCR) ([Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}) and a translational *sapM'-'lacZ* fusion ([Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"}), we ruled out the possibilities of SatS functioning in transcription or translation. Thus, the effect of SatS on SapM levels in the cytoplasm was post-translational, which leaves the most likely role for SatS being to protect SapM protein prior to export.

Mce proteins exported by the SecA2 pathway require SatS {#s2-4}
-------------------------------------------------------

We also tested if SatS had an effect on additional SecA2 substrates. Multiple protein components of Mce transporters, which import lipids, depend on SecA2 to be exported to the cell wall ([@bib17]). Immunoblot analysis of *M. tuberculosis* samples with Mce1A and Mce1E antibodies revealed that the levels of Mce1A and 1E were reduced in cell wall of a ∆*satS* mutant ([Figure 3A](#fig3){ref-type="fig"}), with the defect in the ∆*satS* mutant again being more severe than the ∆*secA2* mutant. Mce importers are conserved in *M. smegmatis* and similar results were obtained upon immunoblotting *M. smegmatis* cell wall fractions with a Mce1D antibody ([Figure 3B](#fig3){ref-type="fig"}). The same effect was seen when a Mce4A~Msm~-HA protein was expressed in *M. smegmatis* ([Figure 3B](#fig3){ref-type="fig"}). In contrast to these results, the level of the SecA2-independent 19 kDa lipoprotein in *M. tuberculosis* and MspA porin in *M. smegmatis* were unchanged in cell wall fractions of ∆*satS* mutants ([Figure 3A and B](#fig3){ref-type="fig"}). Like SapM, total cellular levels of Mce1A and Mce1E were also reduced in the *M. tuberculosis* ∆*satS* mutant compared to H37Rv, the ∆*secA2* mutant and the complemented ∆*satS* strain ([Figure 3C](#fig3){ref-type="fig"}).

![Mce proteins require SatS.\
(**A**) Equalized cell wall fractions of *M. tuberculosis* H37Rv, Δ*secA2*, Δ*satS* and complemented (Δ*satS +psatS~Mtb~*) strains were analyzed by immunoblot using Mce1A, Mce1E, and 19 kDa antibodies to monitor differences in protein levels. (**B**) Equalized *M. smegmatis* mc^2^155, Δ*secA2*, Δ*satS,* and Δ*satS +psatS~Msm~* cell wall fractions were analyzed by immunoblot using Mce1D, HA (Mce4A-HA), and MspA antibodies. (**C**) Equalized protein from whole cell lysates of *M. tuberculosis* H37Rv, ∆*secA2*, ∆*satS* and the complemented strain (∆*satS +psatS~Mtb~*) were immunoblotted for Mce1A, Mce1E, and 19 kDa. (**D**) Equalized cell wall fractions of *M. tuberculosis* H37Rv, Δ*secA2*, and Δ*satS* strains were analyzed by immunoblot using PknG, PhoS1, and 19 kDa antibodies. (**E**) Equalized *M. smegmatis* mc^2^155, Δ*secA2*, and Δ*satS,* cell wall fractions were analyzed by immunoblot using HA (Msmeg1704-HA) and MspA antibodies. Densitometry of blots from three experiments was performed (ImageJ). Percent difference of the mean intensity relative to wild-type is reported below each immunoblot. \*, p\<0.05 by ANOVA and Tukey's post hoc test.](elife-40063-fig3){#fig3}

We next tested whether SatS contributes to export of the SecA2-dependent protein kinase PknG and solute binding protein PhoS1 of *M. tuberculosis,* as well as the solute-binding protein Msmeg1704 of *M. smegmatis* ([@bib16]; [@bib17]; [@bib49]). Immunoblotting of cell wall fractions confirmed that PknG, PhoS1, and Ms1704 depend on SecA2 for export; however, export of these proteins was not impaired in a ∆*satS* mutant ([Figure 3D and F](#fig3){ref-type="fig"}). These data demonstrate a level of specificity in the exported proteins affected by SatS. SatS affects multiple, but not all, of the proteins exported by the SecA2 pathway.

SatS is required for *M. tuberculosis* growth in macrophages {#s2-5}
------------------------------------------------------------

The dramatic reductions in export of SapM and Mce proteins in the ∆*satS* mutant suggested that SatS is required for the pathogenesis of *M. tuberculosis*. SapM functions in limiting *M. tuberculosis* delivery to degradative lysosomes in macrophages while Mce proteins import lipids and thereby contribute to *M. tuberculosis* growth in macrophages and persistence in the host ([@bib50]; [@bib37]; [@bib52]). We tested a role for SatS during growth in macrophages by infecting murine bone marrow-derived macrophages with *M. tuberculosis* H37Rv, the ∆*secA2* mutant, ∆*satS* mutant, or ∆*satS* mutant complemented with *satS~Mtb~*, and comparing intracellular growth over time. Compared to H37Rv, the ∆*satS* mutant demonstrated a significant defect in intracellular growth that was comparable to the previously demonstrated, attenuated phenotype of the ∆*secA2* mutant, and the ∆*satS* mutant phenotype could be complemented ([Figure 4](#fig4){ref-type="fig"}) ([@bib45]; [@bib24]). Thus, like SecA2, SatS plays an important role in enabling *M. tuberculosis* growth in macrophages even though only a subset of SecA2 substrates are affected by SatS.

![SatS contributes to *M. tuberculosis* growth in macrophages.\
Nonactivated BMDM were infected at an MOI of one with *M. tuberculosis* H37Rv + EV, Δ*secA2* + EV, Δ*satS* + EV, or Δ*satS* + psatS, and CFU burden was monitored over the course of a 4 day infection. The fold change in CFU over the course of the 4 day macrophage infection for each strain was calculated; the points represent means of triplicate wells, and the error bars represent standard deviations (SD). \*, p\<0.01; when compared to H37Rv by ANOVA and Tukey's post hoc test. Shown is a representative experiment of four independent experiments.](elife-40063-fig4){#fig4}

SatS and SapM interact {#s2-6}
----------------------

SatS has no sequence similarity to help predict function. However, the post-translational effect of SatS on cellular SapM levels was reminiscent of protein export chaperones of Type III and Type VII secretion systems (T3SS and T7SS), which stabilize their substrates in the cytoplasm and protect them from degradation prior to assisting in their secretion ([@bib47]; [@bib23]). Thus, we considered the possibility that SatS is a protein export chaperone for specific substrates. To perform their functions, protein export chaperones interact with their substrates.

We tested whether SatS interacts with SapM in mycobacteria using co-immunoprecipitation. Immunoprecipitations were performed from *M. smegmatis* strains co-expressing C-terminally tagged SapM-FLAG and C-terminally tagged SatS-HA proteins. These epitope tags did not disrupt SapM or SatS functions ([Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}).

Reasoning that it may be easier to detect a SatS-SapM interaction when SapM export was compromised, we first performed co-immunoprecipitations in a ∆*secA2* mutant background. For these experiments we used a ∆*secA2/*∆*satS* double mutant expressing SatS*~Mtb~* ± HA tag and SapM-FLAG and immunoprecipitated from whole cell lysates using anti-HA agarose. The resulting immunoprecipitates were analyzed by immunoblotting with FLAG antibodies to detect SapM and SatS antibodies to detect SatS. SapM-FLAG was detected in the immunoprecipitates of the samples from the strain expressing SatS*~Mtb~*-HA ([Figure 5A](#fig5){ref-type="fig"}) indicating SatS and SapM interact. As a control, SapM-FLAG was not recovered when the anti-HA immunoprecipitation was performed from a strain expressing untagged SatS*~Mtb~*. Using high percentage (15%) SDS-PAGE, we detected two SapM-FLAG species: a \~ 31 kDa product corresponding to full length preprotein and a \~ 29 kDa product corresponding to the cleaved exported product. We confirmed the assignment of the smaller species as mature, cleaved SapM by immunoblotting lysate from a strain expressing ∆ss-SapM-FLAG ([Figure 5A](#fig5){ref-type="fig"}). It is striking that while the smaller exported species was more abundant in the input lysate, the full length preprotein SapM was the species that co-immunoprecipitated with SatS ([Figure 5A](#fig5){ref-type="fig"}). This is consistent with SatS interacting with SapM preprotein in the cytoplasm, prior to its export and signal sequence cleavage. We investigated whether the signal sequence of SapM is required for the SatS-SapM interaction by immunoprecipitating from a strain co-expressing SatS-HA and ∆ss-SapM-FLAG. SatS-HA and ∆ss-SapM-FLAG co-immunoprecipitated indicating that the signal sequence is not required for the SatS-SapM interaction ([Figure 5A](#fig5){ref-type="fig"}).

![SatS and SapM interact.\
(**A**) Lysate from *M. smegmatis* ∆*secA2*/∆*satS* expressing SapM-FLAG and either SatS*~Mtb~*-HA or SatS*~Mtb~* without a tag, ∆*satS* expressing ∆ss-SapM-FLAG and SatS*~Mtb~*-HA, or mc^2^155 with two empty vectors (as shown above the blot) were used for co-immunoprecipitation using anti-HA conjugated beads. Lysates (left) and immunoprecipitations (right) for each strain were probed with SatS antibody and FLAG antibody for SapM. Two different sizes of SapM-FLAG corresponding to the full-length (signal sequence-containing) and mature (cleaved signal sequence) species were detected. (**B**) Lysate from *M. smegmatis* ∆*satS* expressing SapM-FLAG and either SatS*~Mtb~*-HA or SatS*~Mtb~* without a tag were used for co-immunoprecipitation using anti-HA conjugated beads. Lysates (left) and co-immunoprecipitations (right) for each strain were probed with SatS antibody, FLAG antibody, and MspA antibody. All data are representative of at least three independent experiments.](elife-40063-fig5){#fig5}

We were also able to co-immunoprecipitate SapM-FLAG with SatS-HA from cell lysates of a *M. smegmatis* ∆*satS* strain expressing the same constructs (*i.e.* a *secA2* wild-type background), although there was reproducibly less SapM-FLAG recovered when export was not inhibited ([Figure 5B](#fig5){ref-type="fig"}). Once again, the SapM preprotein species preferentially co-immunoprecipitated with SatS. To address the specificity of SatS interacting with SapM, we also immunoblotted SatS immunoprecipitates with antibody to MspA, which is a cell wall porin that is exported in a SecA2 and SatS-independent manner ([@bib53]; [@bib16]) ([Figure 2F](#fig2){ref-type="fig"}). MspA did not co-immunoprecipitate with SatS ([Figure 5B](#fig5){ref-type="fig"}).

The interaction between the preprotein species of SapM and SatS implied that SatS is a cytoplasmic protein. Using an antibody raised against SatS, we confirmed that in both *M. tuberculosis* and *M. smegmatis* SatS is cytoplasmic ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"} and [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Interestingly, SatS in *M. tuberculosis* and *M. smegmatis* migrated on SDS-PAGE at \~65 kDa rather than at its predicted molecular weight of 46 kDa. SatS purified from *Escherichia coli* also ran at 65 kDa (data not shown).

SatS functions prior to SecA2 {#s2-7}
-----------------------------

If SatS functions as a chaperone for preproteins exported by the SecA2 pathway, we predicted its role should come before the role of SecA2 in exporting SapM across the membrane. To test this order of events, we constructed a *M. smegmatis* ∆*secA2*/∆*satS* double mutant expressing SapM-FLAG and compared the cellular and secreted levels of SapM of the double mutant to single ∆*secA2* or ∆*satS* mutants. If SatS acts prior to SecA2 in exporting SapM, the ∆*satS* mutation should be epistatic to the ∆*secA2* mutation, which proved to be the case. The ∆*secA2*/∆*satS* double mutant exhibited the equivalent dramatic reduction in cellular and secreted levels of SapM as exhibited by the ∆*satS* mutant ([Figures 6A, B and C](#fig6){ref-type="fig"}). Further, there was no additive effect evident on the SapM secretion defect in the ∆*secA2*/∆*satS* double mutant compared to the ∆*satS* mutant ([Figure 6B](#fig6){ref-type="fig"}).

![SatS functions prior to SecA2.\
(**A**) Equal protein from culture supernatants (CFP) from *M. smegmatis* mc^2^155, ∆*secA2*, ∆*satS*, the ∆*secA2/*∆*satS* double mutant, and ∆*secA2/*∆*satS* expressing wild-type SatS (∆*secA2/*∆*satS +psatS~Msm~*) were examined for levels of SapM-FLAG and Mpt32, by Immunoblot. (**B**) Whole cell phosphatase activity assay using the above *M. smegmatis* strains. All strains are expressing SapM, SapM lacking its signal sequence (∆ss-SapM), or an empty vector as indicated. Rates were normalized as described above. (**C**) Whole cell lysates from the above *M. smegmatis* strains were examined for levels of SapM-FLAG and GroEL by Immunoblot. For panels A and C, densitometry of blots from three experiments was performed (ImageJ). Percent difference of the mean intensity relative to wild-type is reported below each immunoblot. All data are representative of at least three independent experiments and all error bars represent standard deviation of the mean of three independent replicates for each strain. n.s. -- no significant difference; \*\*, p\<0.01; \*\*\*\*, p\<0.0001 by ANOVA and Tukey's post hoc test.](elife-40063-fig6){#fig6}

SatS behaves as a chaperone to prevent SapM aggregation {#s2-8}
-------------------------------------------------------

The data thus far were consistent with the hypothesis that SatS functions as a chaperone for a subset of SecA2 dependent substrates. The hallmark of a chaperone is that it binds to unfolded or misfolded regions of proteins to prevent inappropriate interactions, such as aggregation ([@bib14]). To obtain more direct evidence for chaperone activity of SatS, we purified SatS*~Mtb~* and preSapM-His (full length SapM preprotein containing the signal sequence) from *E. coli* and tested the ability of SatS to prevent aggregation in vitro of preSapM-His. preSapM-His was solubilized from inclusion bodies using 8 M urea, rapidly diluted into refolding buffer (150 fold), and its aggregation was followed by change in light scattering at 350 nm. In the absence of SatS, dilution of denatured preSapM-His rapidly led to the formation of light scattering aggregates ([Figure 7](#fig7){ref-type="fig"}). However, inclusion of SatS in the dilution buffer prevented preSapM-His aggregation in a dose-dependent manner ([Figure 7](#fig7){ref-type="fig"}). As controls, BSA and lysozyme did not reduce preSapM-His aggregation ([Figure 7](#fig7){ref-type="fig"}). In fact, BSA or lysozyme modestly had the opposite effect of increasing the light scattering signal. A SatS:preSapM-His molar ratio of 2.5:1 was sufficient to completely ablate preSapM-His aggregation and even a 0.5:1 ratio was sufficient to reduce aggregation by 33%. The data from this in vitro anti-aggregation assay provide strong support for SatS acting as a chaperone and for a direct interaction between SatS and SapM preprotein.

![SatS and SatS~C~ prevent aggregation of SapM *in vitro*.\
Denatured SapM-His was diluted 150 fold to a final concentration of 1 µM in 40 mM HEPES, 100 mM NaCl, pH 7.4. SapM-His aggregation was monitored by light scattered (350 nm) at 25°C in the presence or absence of SatS/SatS~C~ or, as controls, lysozyme or BSA. A molar ratio of 2.5:1 of SatS:SapM-His could prevent SapM-His aggregation and aggregation was significantly reduced using a molar ratio of 0.5:1.](elife-40063-fig7){#fig7}

SatS has a new fold and hydrophobic grooves that share similarity with the preprotein binding sites of the SecB chaperone {#s2-9}
-------------------------------------------------------------------------------------------------------------------------

Although the amino acid sequence of SatS bears no similarity to any known chaperones, the data above support a role for SatS as a protein export chaperone. To gain further insight into SatS function, we collected diffraction quality crystals and determined the crystal structure of SatS to 2.3 Å. Upon inspection, the electron density map only corresponded to the last 185 amino acids (L237-E420) C-domain of the SatS sequence (SatS~C~). The molecular weight of the SatS~C~ crystal was \~25 kDa as determined by SDS-PAGE, indicating that the protein underwent in situ proteolysis in the crystallization buffer. Further investigation revealed striking similarity between the experimentally derived SatS~C~ secondary structure and the predicted secondary structure of the first \~180 amino acids of the N-domain of SatS (SatS~N~) ([Figure 8---figure supplement 1A and B](#fig8s1){ref-type="fig"}). The SatS~C~ and SatS~N~ domains are also similar in size with 41% sequence similarity at the amino acid level ([Figure 8---figure supplement 1A and B](#fig8s1){ref-type="fig"}). This raised the possibility that SatS is comprised of two similar domains with an intervening \~60 amino acids that is predicted to be a flexible, disordered linker ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). Subsequently, constructs expressing SatS~C~ or SatS~N~ in *E. coli* were used to purify the individual domains to homogeneity for crystallization trials. Only SatS~C~ yielded diffraction quality crystals diffracting to 1.4 Å resolution ([Figure 8A](#fig8){ref-type="fig"}).

![SatS has a new fold and hydrophobic grooves that share similarity with the preprotein binding sites of the SecB chaperone.\
(**A**) The overall secondary structure of SatS~C~. The hydrophilicity of SatS~C~ is a colored gradient from cyan (hydrophilic) to maroon (hydrophobic). SatS~C~ exposes \~2,900 Å^2^ of hydrophobic surface. The predicted primary and secondary polypeptide binding site(s) are delineated. (**B**) The overall secondary structure of SecB monomer (PDB ID:1QYN) ([@bib12]). The hydrophilicity of SecB is a colored gradient from cyan (hydrophilic) to maroon (hydrophobic). The primary and secondary client binding site(s) are delineated. Each SecB monomer exposes \~1,900 Å^2^ of hydrophobic surface for client protein interactions ([@bib22]). Molecular graphics and analyses were performed with the UCSF Chimera package ([@bib35]).\
10.7554/eLife.40063.017Figure 8---source data 1.SatS~C~ X-ray Structure Validation Details.](elife-40063-fig8){#fig8}

SatS~C~ displays α/β secondary structure comprised of a mostly parallel, four stranded β-sheet core, flanked by seven α-helices ([Figure 8A](#fig8){ref-type="fig"}). The structure revealed a new fold sharing no similarities with any previously solved protein structure in the PDB based on DELTA-BLAST and VAST similarity searches ([@bib6]; [@bib28]). Although the overall polypeptide fold was not similar to known proteins, the surface of SatS~C~ had pronounced electronegative charge potential that is comparable to many export chaperones, including SecB ([@bib19]). Furthermore, the SatS~C~ structure featured two surface localized hydrophobic grooves, mapped by the Kyte-Doolittle hydrophobicity scale ([@bib25]) ([Figure 8A](#fig8){ref-type="fig"}). These grooves bore similarity to the hydrophobic grooves on SecB ([Figure 8B](#fig8){ref-type="fig"}) that serve as primary and secondary client binding sites to regions of unfolded preproteins ([@bib55]). The proximity of the smaller hydrophobic groove in SatS~C~ (Site 2) to the larger groove in SatS~C~ (Site 1) as well as their amino acid composition (aromatic and bulky side chains) resembled the arrangement and composition of the client binding sites of SecB. The larger of the two hydrophobic grooves in SatS~C~ (Site 1) was comparable in size to the \~60 Å long, main binding site in SecB. Because of the similarities between SecB and SatS~C~, we speculated that SatS~C~ may be sufficient to perform SatS chaperone functions. In fact, when we tested SatS~C~ for chaperone activity in the in vitro anti-aggregation assay, SatS~C~ alone was sufficient to ablate preSapM-HIS aggregation comparable to full length SatS ([Figure 7](#fig7){ref-type="fig"}).

SatS has at least two separable roles in protein export {#s2-10}
-------------------------------------------------------

The majority of *satS* suppressor mutations were expected to behave like *satS* null mutations ([Figure 1B](#fig1){ref-type="fig"}). However, one mutation (3S) that caused a single amino acid substitution (G134D) produced wild-type levels of full length SatS protein when compared to wild-type SatS expressed from the same vector backbone ([Figure 9C](#fig9){ref-type="fig"}). Using this expression plasmid, we tested the importance of the G134 residue, which is ubiquitous in SatS homologs in mycobacteria.

![SatS has at least two separable roles in protein export.\
(**A**) Equal protein from culture supernatants (CFP) from *M. smegmatis* mc^2^155, ∆*secA2*, ∆*satS* and the ∆*satS* mutant expressing either wild-type SatS (∆*satS +psatS~Msm~*) or SatS G134D (∆*satS +psatS~Msm~G134D*) were examined for levels of SapM-FLAG and Mpt32 by Immunoblot. (**B**) Whole cell phosphatase activity assay of *M. smegmatis* strains expressing SapM. Rates were normalized as described above. (**C**) Equal protein from whole cell lysates (WCL) from *M. smegmatis* strains described above were examined for levels of SapM-FLAG, SatS and GroEL by Immunoblot. For panels A and C, densitometry of blots from three experiments was performed (ImageJ). Percent difference of the mean intensity relative to wild-type is reported below each immunoblot. (**D**) Lysate from *M. smegmatis* ∆*satS* expressing SapM-FLAG and either SatS*~Mtb~*G134D-HA or SatS*~Mtb~*G134D without a tag were used for co-immunoprecipitation using anti-HA conjugated beads. Lysates (left) and co-immunoprecipitations (right) for each strain were probed with SatS antibody and FLAG antibody. All data are representative of at least three independent experiments and all error bars represent standard deviation of the mean of three independent replicates for each strain. n.s. -- no significant difference; \*\*\*\*, p\<0.0001 by ANOVA and Tukey's post hoc test.](elife-40063-fig9){#fig9}

We first tested if *satS G134D* could complement the SapM-FLAG secretion defect of the *M. smegmatis* ∆*satS* mutant by immunoblotting culture filtrates. Since *satS G134D* behaved like the ∆*satS* null mutant in suppressing *secA2 K129R*, we predicted that *satS G134D* would fail to complement the SapM secretion defect of the ∆*satS* mutant. Along these lines, *satS G134D* exhibited a SapM secretion defect. However, with either *satS~Msmeg~ G134D* or *satS~Mtb~ G134D* the SapM secretion defect was comparable to the level of the secretion defect of the ∆*secA2* mutant not a ∆*satS* mutant in the immunoblot and whole cell secreted phosphatase activity assays ([Figure 9A and B](#fig9){ref-type="fig"}).

We also evaluated the effect of SatS G134D on cellular SapM levels. To our surprise, *satS G134D* did not behave like a ∆*satS* mutant. Rather, it fully complemented the dramatic ∆*satS* reduction in SapM levels seen in whole cell lysates ([Figure 9C](#fig9){ref-type="fig"}). Furthermore, we were able to co-immunoprecipitate SatS G134D-HA and SapM-FLAG preprotein ([Figure 9D](#fig9){ref-type="fig"}) indicating that SatS G134D retains the ability to interact with SapM-FLAG. Our discovery that SatS G134D still binds SapM preprotein and maintains cellular levels of SapM, yet *satS G134D* exhibits a defect in SapM secretion equivalent to that of a ∆*secA2* mutant, indicates that SatS has more than one role in SapM secretion by the SecA2 pathway. Moreover, these multiple functions of SatS in export can be uncoupled.

Discussion {#s3}
==========

As with all bacterial pathogens, the protein export pathways of *M. tuberculosis* are critical to virulence. Here, we identified SatS, a previously uncharacterized protein of unknown function, as a new protein export factor with a role in intracellular growth of *M. tuberculosis*. We further discovered multiple properties of SatS that indicate a function as a protein export chaperone. As the amino acid sequence of SatS bears no similarity to chaperones and the structure of the SatS~C~ domain reveals a new fold, SatS appears to represent a new type of protein export chaperone.

Suppressor analysis led to the identification of SatS {#s3-1}
-----------------------------------------------------

Suppressor analysis is a classic approach for identifying genes in pathways, and it was used extensively in early studies of the general Sec pathway in *E. coli* ([@bib5]; [@bib18]). Here, we carried out a suppressor screen using *secA2 K129R*, which encodes a variant of SecA2 that is unable to hydrolyze ATP ([@bib40]). Past studies lead to a model where SecA2 K129R is locked in a nonfunctional complex with SecY while attempting to export its substrates ([@bib27]). As a result, SecA2 K129R is trapped at the membrane and SecY proteins are degraded ([@bib27]). Our discovery that loss-of-function *satS* mutations suppress *secA2 K129R* phenotypes suggests that SatS is required for the detrimental interaction of SecA2 K129R with SecYEG to occur. In fact, deletion of *satS* significantly reversed SecA2 K129R retention at the membrane and the associated SecY degradation, which is consistent with avoidance of the interaction. By extension, these results support a role for SatS in enabling wild-type SecA2 to interact with the SecYEG channel.

One possibility for how SatS promotes SecA2 interactions with the SecYEG channel is that SatS is a core component of a SecA2-specific export apparatus with a function mediating the interaction between SecA2 and SecYEG. However, if SatS were to function this way, we would expect all SecA2-dependent substrates would require SatS for export, which was not the case. An alternate possibility is that in order for SecA2 to be delivered to or engage the SecYEG channel it must first be bound to a substrate in a translocation competent state and that SatS functions as a protein export chaperone that facilitates this SecA2-substrate interaction. We favor this role for SatS as it would not only help explain why phenotypes of *secA2 K129R* depend on the presence of SatS but it is also consistent with our identification of an interaction between SatS and SapM and the chaperone activities of SatS. However, a question raised by this model is how elimination of SatS suppresses *secA2 K129R* if there are also SatS-independent proteins that could interact with SecA2 K129R. The answer may be that the threshold for phenotypic suppression does not require all SecA2 K129R to be diverted from the SecYEG channel.

SatS as a protein export chaperone {#s3-2}
----------------------------------

Molecular chaperones are defined by their ability to transiently bind unfolded regions of proteins and, thereby, protect them from inappropriate interactions, such as aggregation, incorrect/premature folding or degradation ([@bib14]). Chaperones are a common component of protein export systems, with SecB of the general Sec pathway in Gram-negative bacteria and Type III Secretion System Chaperones (T3SCs) being examples. In mycobacteria, EspG proteins of Type VII Secretion Systems are the only protein export chaperones identified so far ([@bib11]; [@bib13]). As a subset of molecular chaperones, protein export chaperones have additional functions in export, such as targeting substrates to export machinery. Although there is a notable lack of amino acid and structural similarity between different types of protein export chaperones, commonalities exist. Protein export chaperones are all highly acidic (pI \<5.0) proteins that transiently interact with their substrates in the cytoplasm and remain in the cytoplasm when the substrate is exported ([@bib38]; [@bib47]; [@bib13]). Additionally, a hallmark of a protein export chaperone is that its role is limited to a subset of the proteins exported by a given system ([@bib10]; [@bib46]; [@bib11]). Finally, in some cases, the genes encoding the chaperone and substrate are co-expressed and in an operon ([@bib33]; [@bib11]).

SatS has many features of a protein export chaperone. SatS is a highly acidic (pI 3.83), cytoplasmic protein with a role promoting export of a subset of the proteins exported by the SecA2 pathway. Further, the *satS* and *sapM* genes are co-transcribed in an operon and we obtained evidence of a SatS:SapM interaction occurring in mycobacteria. SatS preferentially interacted with the full-length preprotein of SapM indicating that the interaction occurs in the cytoplasm prior to SapM export. However, like other protein export chaperones (T3SCs, SecB, and EspG~5~) ([@bib43]; [@bib22]; [@bib13]) where binding occurs in regions of the mature domain of the substrate, the signal sequence was not required for the SatS-SapM interaction. The in vitro anti-aggregation effect of SatS on SapM preprotein provided the most direct proof of a SatS:SapM interaction and a chaperone function for SatS. Finally, in the absence of SatS, the level of SapM in the cytoplasm was dramatically reduced. This effect of SatS on intracellular SapM levels is post-translational and is also reminiscent of effects of T3SCs and EspG chaperones ([@bib46]; [@bib23]).

In comparison to the dramatic reduction in intracellular SapM in the ∆*satS* mutant, the ∆*secA2* mutant exhibited only a modest effect on intracellular SapM levels. This difference in intracellular SapM levels translates to the more severe secretion defect of the ∆*satS* mutant versus the ∆*secA2* mutant. Export defects of mycobacterial ∆*secA2* mutants are never 100% (i.e. residual export is observed in ∆*secA2* mutants) ([@bib8]; [@bib49]; [@bib17]; [@bib57]). The pathway responsible for the residual export in a ∆*secA2* mutant remains unknown although the general Sec pathway involving SecA1 is an attractive candidate. Thus, it is possible that SatS also works with SecA1 and the general Sec pathway, at least when SecA2 is absent. Moreover, we cannot rule out the possibility that there are SatS substrates that are exported in a completely SecA2-independent manner. Additional studies will be required to address these unknowns.

Because of the dramatically reduced levels of SapM in the whole cell lysate of the Δ*satS* mutant, it was not immediately clear if the role of SatS in SapM secretion was solely to maintain intracellular levels of SapM preprotein or if SatS had additional roles. By evaluating the *satS G134D* mutant, we revealed the existence of at least one additional role for SatS in promoting SapM secretion. In the *satS G134D* mutant, intracellular SapM was maintained at wild-type levels; yet, there remained a SapM secretion defect. It is noteworthy that the SapM secretion defect of the *satS G134D* mutant was on the order of a ∆*secA2* mutant, which is consistent with SatS G134 working in the SecA2 pathway. Future studies should address this second function, which could be a role for SatS in targeting substrates to the SecA2 pathway and/or in maintaining SapM in an unfolded state for protein translocation across SecYEG.

The SatS structure defines a new fold with hydrophobic grooves typical of substrate binding sites {#s3-3}
-------------------------------------------------------------------------------------------------

Although we set out to solve the structure of SatS in its entirety, we were only able to obtain structural information for the C-terminal half of the protein (SatS~C~), which arose during crystallization. However, the primary sequence and secondary structure similarity between the N-terminal and C-terminal halves of SatS raise the possibility of SatS being comprised of tandem SatS~C~-like domains. Investigation of the SatS~C~ structure revealed a large network of negatively charged amino acids surrounding two surface exposed hydrophobic grooves, which are similar in arrangement, shape and size to the hydrophobic client binding sites of a SecB monomer ([@bib22]). In the solution structure of SecB in complex with a preprotein, the unfolded preprotein wraps around the SecB tetramer through interactions with the hydrophobic client binding sites. This binding architecture helps explain the means by which SecB maintains Sec preproteins in an unfolded state, as is required for their transport through the SecYEG channel ([@bib48]). The similarity in hydrophobic grooves in SatS and SecB is intriguing since SatS works with the SecA2 pathway, which also uses the SecYEG channel. Moreover, these similarities suggest that the hydrophobic grooves in SatS may serve as similar substrate binding sites. In fact, in the anti-aggregation assay the SatS~C~ domain was sufficient for preventing SapM preprotein aggregation, indicating that SatS~C~ is capable of directly interacting with SapM preprotein. Mycobacteria lack a canonical SecB protein export chaperone, although in *M. tuberculosis* there is a SecB-like protein that functions as a chaperone for a toxin-antitoxin system ([@bib7]). Thus, even though SecB and SatS are not evolutionarily conserved, it is interesting to speculate a SecB-like function for SatS. SatS may be an adaptation for export of specific proteins by Actinomycetales, since SatS orthologs are not found outside of this order.

SatS is required for growth of *M. tuberculosis* in macrophages {#s3-4}
---------------------------------------------------------------

Prior TraSH/Tnseq analyses using pooled libraries of transposon mutants predicted SatS to be required during murine and macrophage infections ([@bib39]; [@bib56]); however, this prediction had never been validated. Here, using a ∆*satS* mutant and a complemented strain, we directly demonstrated a role for SatS in *M. tuberculosis* growth in macrophages. These data argue for an important role of SatS and its specific substrates in pathogenesis. Given that only a subset of SecA2 substrates are affected by SatS, future studies should include investigation of SatS substrates and their contribution to pathogenesis. Since our approach for identifying SatS substrates was not exhaustive, there may also exist SatS-dependent proteins that remain to be identified.

Conclusion {#s3-5}
----------

By way of a genetic screen in *M. smegmatis*, we identified a new protein SatS with roles in protein export in *M. tuberculosis*. This work not only expands our understanding of the specialized SecA2 protein export pathway of mycobacteria but it provides important functional information for a previously uncharacterized *M. tuberculosis* protein that contributes to pathogenesis. Further, by assigning a chaperone function to SatS, our studies expand our appreciation of the diversity of chaperones in biological systems. Although chaperones have common functions, substantial structural diversity exists among these proteins, which is further highlighted by the new fold revealed in the structure of SatS~C~.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\       Designation            Source or\                                               Identifiers                                                      Additional information
  (species) or\                              reference                                                                                                                 
  resource                                                                                                                                                             
  ------------------- ---------------------- -------------------------------------------------------- ---------------------------------------------------------------- -------------------------------
   Strain,\           MBTB508;\              [@bib57]                                                                                                                  *M. tuberculosis*\
  *Mycobacterium*\    (WT Mtb)                                                                                                                                         wild-type H37Rv + Ev\
  *tuberculosis*                                                                                                                                                       (pMV306.kan)

  Strain,\            MBTB443                [@bib57]                                                                                                                  ∆*secA2* + Ev (pMV306.kan)
  *M. tuberculosis*                                                                                                                                                    

  Strain,\            MBTB512                this paper                                                                                                                ∆*satS* + Ev (pMV306.kan)
  *M. tuberculosis*                                                                                                                                                    

  Strain,\            MBTB513                this paper                                                                                                                ∆*satS + psatS* (pBM13)
  *M. tuberculosis*                                                                                                                                                    

  Strain,\            mc^2^155;\             [@bib42]                                                                                                                  *M. smegmatis*\
  *Mycobacterium*\    (WT Msm)                                                                                                                                         wild-type (WT)
  *smegmatis*                                                                                                                                                          

  Strain,\            NR116                  [@bib40]                                                                                                                  ∆*secA2*
  *M. smegmatis*                                                                                                                                                       

  Strain,\            BAF1                   this paper                                                                                                                ∆*secA2*/∆*satS*
  *M. smegmatis*                                                                                                                                                       

  Strain,\            BM10                   this paper                                                                                                                ∆*satS*
  *M. smegmatis*                                                                                                                                                       

  Recombinant\        satSMtb\               this paper                                               GCGGTACCGCCGTGGGTCAACTTCAGTAAC                                   Contains engineered\
  DNA reagent\        US flank F                                                                                                                                       KpnI site, used to amplify\
  (primers)                                                                                                                                                            US flank for pSM42

  Recombinant\        satSMtb US flank R     this paper                                               GCGTCTAGAGGTGCTGATGATCTCGTCGATG                                  Contains engineered\
  DNA reagent\                                                                                                                                                         XbaI site, used to amplify\
  (primers)                                                                                                                                                            US flank for pSM42

  Recombinant\        satSMtb DS flank F     this paper                                               GCGAAGCTTATGATCGACCGATCTTCCTG                                    Contains engineered\
  DNA reagent\                                                                                                                                                         HindIII site, used to\
  (primers)                                                                                                                                                            amplify\
                                                                                                                                                                       DS flank for pSM42

  Recombinant\        satSMtb DS flank R     this paper                                               GCGACTAGTCGGGCTGTTTTCTACGTTGT                                    Contains engineered\
  DNA reagent\                                                                                                                                                         SpeI site, used to amplify\
  (primers)                                                                                                                                                            DS flank for pSM42

  Recombinant\        satSMsm US flank F     this paper                                               AACATATGCGCAACTGGGTGTGCCGTATCACTG                                Contains engineered NdeI\
  DNA reagent\                                                                                                                                                         site, used to amplify US\
  (primers)                                                                                                                                                            flank for pLL50

  Recombinant\        satSMsm US flank R     this paper                                               AAGCTAGCAGCAGCCATGCGGCACAGCCTAAC                                 Contains engineered\
  DNA reagent\                                                                                                                                                         NheI site, used to amplify\
  (primers)                                                                                                                                                            US flank for pLL50

  Recombinant\        satSMsm DS flank F     this paper                                               ATGCTAGCTCCCGGCTCCGTCAGGAGTAGCG                                  Contains engineered\
  DNA reagent\                                                                                                                                                         NheI site, used to amplify\
  (primers)                                                                                                                                                            DS flank for pLL50

  Recombinant\        satSMsm DS flank R     this paper                                               AACATATGAGCCACCCGGCGAAATTGAAGCCAC                                Contains engineered\
  DNA reagent\                                                                                                                                                         NdeI site, used to amplify\
  (primers)                                                                                                                                                            DS flank for pLL50

  Recombinant\        1684-F-Native          this paper                                               AGTTAATTAACGTGTGCTCGACGGCCTGGTTGCC                               Contains engineered\
  DNA reagent\                                                                                                                                                         PacI site, used to construct\
  (primers)                                                                                                                                                            satSMsm plasmids pBM4,\
                                                                                                                                                                       pBM22, and pBM23

  Recombinant\        1684 R                 this paper                                               AATGGCCACTACTCCTGACGGAGCCGGGACTCCAC                              Contains engineered\
  DNA reagent\                                                                                                                                                         BalI site, used to construct\
  (primers)                                                                                                                                                            satSMsm plasmids pBM4\
                                                                                                                                                                       and pBM22

  Recombinant\        1684 R-HA              this paper                                               ATTGGCCATCAGGCGTAGTCCGGCACGTCGTACGGGTACTCCTGACGGAGCCGGGACTCCAC   Contains engineered HA\
  DNA reagent\                                                                                                                                                         tag and BamHI site, used to\
  (primers)                                                                                                                                                            construct satSMsm-HA plasmid\
                                                                                                                                                                       pBM23

  Recombinant\        Rv3311-F               this paper                                               AATGGCCACTGACCTCGTACCCATCCGCTTGAG                                Contains engineered\
  DNA reagent\                                                                                                                                                         MscI site, used to construct\
  (primers)                                                                                                                                                            satSMtb plasmids pBM13,\
                                                                                                                                                                       pBM60, and pBM80

  Recombinant\        Rv3311-R               this paper                                               AATGGCCACTAGCCTTCGCCGGCTGAC                                      Contains engineered\
  DNA reagent\                                                                                                                                                         MscI site, used to construct\
  (primers)                                                                                                                                                            satSMtb plasmid pBM80

  Recombinant\        Rv3311-HA-R            this paper                                               TTAAGCTTCGCGCCTGAGCCGCGACTCC                                     Contains engineered\
  DNA reagent\                                                                                                                                                         HindIII site, used to\
  (primers)                                                                                                                                                            construct satSMtb\
                                                                                                                                                                       plasmids\
                                                                                                                                                                       pBM13 and pBM60

  Recombinant\        Rv3311-G134D-F         this paper                                               GCCCAGGATGGGATTGTCGTTGAAGAACTTCGA                                Used for site directed\
  DNA reagent\                                                                                                                                                         mutagenesis on pBM80 to\
  (primers)                                                                                                                                                            generate pBM87

  Recombinant\        Rv3311-G134D-R         this paper                                               TCGAAGTTCTTCAACGACAATCCCATCCTGGGC                                Used for site directed\
  DNA reagent\                                                                                                                                                         mutagenesis on pBM80\
  (primers)                                                                                                                                                            to generate pBM87

  Recombinant\        SapM-F                 this paper                                               TGGCCAACCGCGGAATCCAGGCTCTC                                       Contains engineered\
  DNA reagent\                                                                                                                                                         MscI site, used to\
  (primers)                                                                                                                                                            construct sapM plasmids\
                                                                                                                                                                       pJTS130, and pBM56

  Recombinant\        Dss-SapM-F             this paper                                               TGGCCAAGACCTTCGCGCACGTGG                                         Contains engineered\
  DNA reagent\                                                                                                                                                         MscI site, used to\
  (primers)                                                                                                                                                            construct sapM plasmids\
                                                                                                                                                                       pJTS132 and pBM61

  Recombinant\        SapM-R                 this paper                                               AAGCTTCCATGCGGCACAGAATAGCGAC                                     Contains engineered\
  DNA reagent\                                                                                                                                                         HindIII site, used\
  (primers)                                                                                                                                                            to construct\
                                                                                                                                                                       sapM plasmids\
                                                                                                                                                                       pJTS130 and\
                                                                                                                                                                       pJTS132

  Recombinant\        SapM-FLAG-R            this paper                                               ACTAAGCTTTCACTT\                                                 Contains engineered\
  DNA reagent\                                                                                        GTCGTCGTCGTCCTTGTAGTCCGTATACGAGCCGCCGTCGCCCCAAATATCG             linker-FLAG and\
  (primers)                                                                                                                                                            HindIII site,\
                                                                                                                                                                       used to construct\
                                                                                                                                                                       sapM\
                                                                                                                                                                       plasmids pBM56\
                                                                                                                                                                       and pBM61

  Recombinant\        SapM-Promoter F        this paper                                               ACTGGTACCTTCACGCAGCGTGGTCAGTC                                    Used with EcoRI site in\
  DNA reagent\                                                                                                                                                         TOPO to construct\
  (primers)                                                                                                                                                            sapM-lacZ\
                                                                                                                                                                       reporter pBM94

  Recombinant\        PsapM-LacZ R           this paper                                               AGGATCCATTCCGCGGAGCATGCCGGGAG                                    Contains engineered\
  DNA reagent\                                                                                                                                                         BamHI site to construct\
  (primers)                                                                                                                                                            sapM-lacZ reporter pBM94

  Recombinant\        SapM-3311 gap F        this paper                                               GACGGGTTATGCGACCAATG                                             Amplify the region\
  DNA reagent\                                                                                                                                                         between\
  (primers)                                                                                                                                                            sapM and satS\
                                                                                                                                                                       for RT-PCR

  Recombinant\        SapM-3311 gap R        this paper                                               CTCAAGCGGATGGGTACGAG                                             Amplify the region\
  DNA reagent\                                                                                                                                                         between sapM and satS\
  (primers)                                                                                                                                                            for RT-PCR

  Recombinant\        Mce4A hsp60 F          this paper                                               AAGATATCCGAACGGAAACGCCAAACG                                      Contains engineered\
  DNA reagent\                                                                                                                                                         EcoRV site, used\
  (primers)                                                                                                                                                            to construct\
                                                                                                                                                                       mce4AMsmeg-HA\
                                                                                                                                                                       plasmids\
                                                                                                                                                                       pBM44

  Recombinant\        Mce4A hsp60 R          this paper                                               TAAGCTTCGTCCCTTTCCGCGAAC                                         Contains\
  DNA reagent\                                                                                                                                                         engineered HindIII\
  (primers)                                                                                                                                                            site, used to construct\
                                                                                                                                                                       mce4A\
                                                                                                                                                                       Msmeg-HA plasmids\
                                                                                                                                                                       pBM44

  Recombinant\        sigA RT F              this paper                                               AAGCGAACAGCGGCGAAGTC                                             qRT-PCR primer for sigA
  DNA reagent\                                                                                                                                                         
  (primers)                                                                                                                                                            

  Recombinant\        sigA RT R              this paper                                               TTCGGGATGGTGCTGGTCGTAG                                           qRT-PCR primer for sigA
  DNA reagent\                                                                                                                                                         
  (primers)                                                                                                                                                            

  Recombinant\        sapM RT F              this paper                                               ATCGTTGCTGGCCTCATGG                                              qRT-PCR primer for sapM
  DNA reagent\                                                                                                                                                         
  (primers)                                                                                                                                                            

  Recombinant\        sapM RT R              this paper                                               AGGGAGCCGACTTGTTACC                                              qRT-PCR primer for sapM
  DNA reagent\                                                                                                                                                         
  (primers)                                                                                                                                                            

  Recombinant\        sapM E. coli F         this paper                                               GTCTCTCCCATGC\                                                   Used to express sapM\
  DNA reagent\                                                                                        TCCGCGGAATCCAG                                                   in the E. coli pMSCG\
  (primers)                                                                                                                                                            -28 vector

  Recombinant\        sapM E. coli R         this paper                                               GGTTCTCCCCAGCGTCGCCCCAAATATCGGTTATTGG                            Used to express sapM\
  DNA reagent\                                                                                                                                                         in the E. coli\
  (primers)                                                                                                                                                            pMSCG-28 vector

  Recombinant\        satS E. coli F         this paper                                               TTTTTTCATATGGTTGCTGACCTCGTACCCATC                                Contains engineered\
  DNA reagent\                                                                                                                                                         NdeI site, used to express\
  (primers)                                                                                                                                                            satS in E. coli\
                                                                                                                                                                       Pet28b vector

  Recombinant\        satSC E. coli F        this paper                                               TTTTTTCATATGCGGGACTTCTGGTTGCAG                                   Contains engineered\
  DNA reagent\                                                                                                                                                         NdeI site, used to express\
  (primers)                                                                                                                                                            satSC in E. coli\
                                                                                                                                                                       Pet28b vector

  Recombinant\        satS/satSC E. coli R   this paper                                               TTTTTTAAGCTTCT\                                                  Contains engineered\
  \                                                                                                   ATTCGCGCCTGAGCC                                                  HindIII\
  DNA reagent\                                                                                                                                                         site, used to express\
  (primers)                                                                                                                                                            satS/satSC in E. coli\
                                                                                                                                                                       Pet28b\
                                                                                                                                                                       vector

  Recombinant\        pMV261.kan             [@bib44]                                                                                                                  Multicopy mycobacterial\
  DNA reagent\                                                                                                                                                         vector with hsp60\
  (plasmids)                                                                                                                                                           promoter\
                                                                                                                                                                       (KanR)

  Recombinant\        pMV361.kan             [@bib44]                                                                                                                  Single-copy\
  DNA reagent\                                                                                                                                                         mycobacterial\
  (plasmids)                                                                                                                                                           vector with hsp60\
                                                                                                                                                                       promoter,\
                                                                                                                                                                       integrates in\
                                                                                                                                                                       mycobacteriophage\
                                                                                                                                                                       L5 attB site (KanR)

  Recombinant\        pMV306.kan             [@bib44]                                                                                                                  Single-copy, promoterless\
  DNA reagent\                                                                                                                                                         mycobacterial\
  (plasmids)                                                                                                                                                           vector, integrates\
                                                                                                                                                                       in mycobacteriophage L5\
                                                                                                                                                                       attB site (KanR)

  Recombinant\        pJSC77                 [@bib21]                                                                                                                  Multicopy mycobacterial\
  DNA reagent\                                                                                                                                                         vector, HA tag cloned into\
  (plasmids)                                                                                                                                                           pMV261 (KanR)

  Recombinant\        pLL2                   [@bib27]                                                                                                                  single-copy mycobacterial\
  DNA reagent\                                                                                                                                                         shuttle vector,\
  (plasmids)                                                                                                                                                           integrates in\
                                                                                                                                                                       mycobacteriophage\
                                                                                                                                                                       Tweety\
                                                                                                                                                                       attB site (HygR)

  \                   pYA810                 [@bib20]                                                                                                                  Integrating M. smegmatis\
  Recombinant\                                                                                                                                                         secA2 complementation\
  DNA reagent\                                                                                                                                                         plasmid in\
  (plasmids)                                                                                                                                                           pMV361.kan (KanR)

  Recombinant\        pNR25                  [@bib40]                                                                                                                  Integrating\
  DNA reagent\                                                                                                                                                         M. smegmatis\
  (plasmids)                                                                                                                                                           secA2 K129R\
                                                                                                                                                                       in pMV361.kan\
                                                                                                                                                                       (KanR)

  Recombinant\        pLL50                  this paper                                                                                                                Suicide vector pMP62\
  DNA reagent\                                                                                                                                                         containing flanking\
  (plasmids)                                                                                                                                                           regions to\
                                                                                                                                                                       delete satSMsm (HygR)

  Recombinant\        pBM11                  this paper                                                                                                                Suicide vector pMP62\
  DNA reagent\                                                                                                                                                         containing\
  (plasmids)                                                                                                                                                           secA2Msm and\
                                                                                                                                                                       flanking regions\
                                                                                                                                                                       to reintroduce\
                                                                                                                                                                       secA2 to the BAF1\
                                                                                                                                                                       strain (HygR)

  Recombinant\        pBM4                   this paper                                                                                                                satSMsm under native\
  DNA reagent\                                                                                                                                                         promoter in pLL2 (HygR)
  (plasmids)                                                                                                                                                           

  Recombinant\        pBM80                  this paper                                                                                                                satSMtb under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pLL2 (HygR)
  (plasmids)                                                                                                                                                           

  Recombinant\        pSM42                  this paper                                                                                                                satSMtb upstream and\
  DNA reagent\                                                                                                                                                         downstream flanks\
  (plasmids)                                                                                                                                                           inserted\
                                                                                                                                                                       into pYUB854 (HygR)

  Recombinant\        pSM45                  this paper                                                                                                                Phasmid for knocking\
  DNA reagent\                                                                                                                                                         out satSMtb (HygR)
  (plasmids)                                                                                                                                                           

  Recombinant\        pSM60                  this paper                                                                                                                Phage for knocking\
  DNA reagent\                                                                                                                                                         out satSMtb (HygR)
  (plasmids)                                                                                                                                                           

  Recombinant\        pBM13                  this paper                                                                                                                satSMtb under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pMV306.kan\
  (plasmids)                                                                                                                                                           (KanR)

  Recombinant\        pJTS130                [@bib57]                                                                                                                  sapM under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pMV261.kan\
  (plasmids)                                                                                                                                                           (KanR)

  Recombinant\        pJTS132                this paper                                                                                                                ∆ss-sapM under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pMV261.\
  (plasmids)                                                                                                                                                           kan (KanR)

  Recombinant\        pYUB76                 [@bib3]                                                                                                                   Multicopy mycobacterial\
  DNA reagent\                                                                                                                                                         shuttle vector with\
  (plasmids)                                                                                                                                                           promoterless lacZ gene\
                                                                                                                                                                       (KanR)

  Recombinant\        pBM94                  this paper                                                                                                                psapM-sapM'-'lacZ in\
  DNA reagent\                                                                                                                                                         pYUB76 (KanR)
  (plasmids)                                                                                                                                                           

  Recombinant\        pBM56                  this paper                                                                                                                sapM under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pMV261.kan\
  (plasmids)                                                                                                                                                           containing a\
                                                                                                                                                                       C-terminal linker\
                                                                                                                                                                       and FLAG tag (KanR)

  Recombinant\        pBM60                  this paper                                                                                                                satSMtb under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pLL2\
  (plasmids)                                                                                                                                                           containing a\
                                                                                                                                                                       C-terminal HA tag (HygR)

  Recombinant\        pBM61                  this paper                                                                                                                ∆ss-sapM under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pMV261.kan\
  (plasmids)                                                                                                                                                           containing a\
                                                                                                                                                                        C-terminal linker\
                                                                                                                                                                       and FLAG tag (KanR)

  Recombinant\        pBM22                  this paper                                                                                                                satSMsm under native\
  DNA reagent\                                                                                                                                                         promoter\
  (plasmids)                                                                                                                                                           in pLL2 amplified\
                                                                                                                                                                       from suppressor\
                                                                                                                                                                       3S to contain the\
                                                                                                                                                                       G134D point\
                                                                                                                                                                       mutation (HygR)

  Recombinant\        pBM23                  this paper                                                                                                                satSMsm under native\
  DNA reagent\                                                                                                                                                         promoter in pLL2\
  (plasmids)                                                                                                                                                           amplified\
                                                                                                                                                                       from suppressor 3S to\
                                                                                                                                                                       contain the\
                                                                                                                                                                       G134D point mutation\
                                                                                                                                                                       and containing\
                                                                                                                                                                       a C-terminal HA tag (HygR)

  Recombinant\        pBM87                  this paper                                                                                                                satSMtb under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pLL2\
  (plasmids)                                                                                                                                                           with point\
                                                                                                                                                                       mutation G134D\
                                                                                                                                                                       generated by\
                                                                                                                                                                       site directed\
                                                                                                                                                                       mutagenesis (HygR)

  Recombinant\        pBM44                  this paper                                                                                                                Mce4AMsm under hsp60\
  DNA reagent\                                                                                                                                                         promoter in pJSC77\
  (plasmids)                                                                                                                                                           containing a\
                                                                                                                                                                       C-terminal HA tag (KanR)

  Recombinant\        pHSG58                 [@bib20]                                                                                                                  Multi-copy Ms1704-HA\
  DNA reagent\                                                                                                                                                         expression vector\
  (plasmids)                                                                                                                                                           under hsp60\
                                                                                                                                                                       promoter (KanR)

  Recombinant\        pRH1                   this paper                                                                                                                sapM in the E. coli\
  DNA reagent\                                                                                                                                                         pMSCG-28 vector\
  (plasmids)                                                                                                                                                           containing a\
                                                                                                                                                                       C terminal His tag\
                                                                                                                                                                       (CarbR)

  Recombinant\        pRH2                   this paper                                                                                                                satS in E. coli Pet28b\
  DNA reagent\                                                                                                                                                         vector (KanR)
  (plasmids)                                                                                                                                                           

  Recombinant\        pRH3                   this paper                                                                                                                satSC in E. coli\
  DNA reagent\                                                                                                                                                         Pet28b\
  (plasmids)                                                                                                                                                           vector (KanR)

  Antibody            Rabbit polyclonal\     this paper                                               rabbit polyclonal\                                               (1:20,000)
                      anti-SatS                                                                       raised against\                                                  
                                                                                                      SatS*Mtb:*\                                                      
                                                                                                      PA6753 for *Mtb*\                                                
                                                                                                      and PA6754 for\                                                  
                                                                                                      *Msm*                                                            

  Antibody            Rabbit polyclonal\     [@bib50]                                                                                                                  Provided by Vojo\
                      anti-SapM                                                                                                                                        Deretic; (1:5,000)

  Antibody            Rabbit polyclonal\     [@bib17]                                                                                                                  Provided by Chris\
                      anti-Mce1A                                                                                                                                       Sassetti; (1:10,000)

  Antibody            Rabbit polyclonal\     [@bib17]                                                                                                                  Provided by Chris\
                      anti-Mce1E                                                                                                                                       Sassetti; (1:10,000)

  Antibody            Rabbit polyclonal\     [@bib34]                                                                                                                  Provided by Chris\
                      anti-Mce1D                                                                                                                                       Sassetti; (1:10,000)

  Antibody            Rabbit polyclonal\     [@bib17]                                                                                                                  Provided by Douglas\
                      anti-19kDa\                                                                                                                                      Young; (1:20,000)

  Antibody            Mouse monoclonal\      NIH Biodefense\                                          Cat. \#: IT23                                                    (1:20,000)
                      anti-PhoS1             and Emerging\                                                                                                             
                                             Infections Research\                                                                                                      
                                             Resources Repository,\                                                                                                    
                                             NIAID                                                                                                                     

  Antibody            Rabbit polyclonal\     [@bib17]                                                                                                                  Provided by Yossef\
                      anti-PknG                                                                                                                                        Av-Gay; (1:5,000)

  Antibody            Rabbit polyclonal\     [@bib40]                                                                                                                  (1:20,000)
                      anti-SecA2                                                                                                                                       

  Antibody            Rabbit polyclonal\     \                                                                                                                         Provided by Murty\
                      anti-SigA              [@bib17]                                                                                                                  Madiraju; (1:15,000)

  Antibody            Rabbit polyclonal\     [@bib16]                                                                                                                  Provided by Michael\
                      anti-MspA                                                                                                                                        Niederweis; (1:5,000)

  Antibody            Rabbit polyclonal\     [@bib27]                                                                                                                  (1:250)
                      anti-SecY                                                                                                                                        

  Antibody            Rabbit polyclonal\     NIH Biodefense and\                                      Cat. \#: NR-13807                                                (1:5,000)
                      anti-Mpt32             Emerging Infections\                                                                                                      
                                             Research Resources\                                                                                                       
                                             Repository, NIAID                                                                                                         

  Antibody            Rabbit\                Sigma-Aldrich                                            Cat. \#: F7425                                                   (1:10,000)
                      polyclonal\                                                                                                                                      
                      anti-FLAG                                                                                                                                        

  Antibody            Mouse monoclonal\      Sigma-Aldrich                                            clone M2                                                         (1:10,000)
                      anti-FLAG                                                                                                                                        

  Antibody            Mouse monoclona\       Sigma-Aldrich                                            clone HA-7                                                       (1:10,000)
                      l anti-HA                                                                                                                                        

  Antibody            Mouse monoclonal\      Abgent                                                   Cat. \#: AM1010a                                                 (1:20,000)
                      anti-HIS                                                                                                                                         

  Antibody            Goat polyclonal\       Bio-Rad                                                  Cat. \#: 1721011                                                 (1:25,000)
                      anti-Mouse IgG                                                                                                                                   

  Antibody            Goat polyclonal\       Bio-Rad                                                  Cat. \#: 1706515                                                 (1:25,000)
                      anti-Rabbit IgG                                                                                                                                  

  Chemical\           p-Nitrophenyl\         NEB                                                      Cat. \#: P0757                                                   
  compound,\          Phosphate (PNPP)                                                                                                                                 
  drug                                                                                                                                                                 

  Software,\          ImageJ                 <https://imagej.nih.gov/ij/>                             RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)     
  algorithm                                                                                                                                                            

  Software,\          Graphpad Prism 7       <https://www.graphpad.com/> scientific-software/prism/   RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)     
  algorithm                                                                                                                                                            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmids, bacterial strains, and culture conditions {#s4-1}
---------------------------------------------------

For plasmid construction, PCR products were amplified with primers described in the Key Resources Table, ligated into TOPO cloning vectors (Invitrogen, Carlsbad, CA), digested with restriction enzymes, and ligated into their final vectors. Final vectors are described in the Key Resources Table. In all cases, newly constructed plasmids were verified by sequencing and diagnostic digests. In the case of SatS G134D plasmids, *satS~Msm~* was amplified by PCR from the 3S suppressor and *satS~Mtb~ G134D* was designed using site directed mutagenesis (SDM) on the *satS~Mtb~* complementation plasmid pBM81. Amino acid G134 was confirmed to be highly conserved in mycobacterial SatS homologs using ConSurf ([@bib1]).

*M. tuberculosis* and *M. smegmatis* strains are described in the Key Resources Table. For all experiments in this study, wildtype and mutant strains had empty vector plasmids to enable comparison to complemented strains. *M. tuberculosis* was grown at 37°C in Middlebrook 7H9/7H11 supplemented with 1x albumin dextrose saline (ADS), 0.5% glycerol and 0.025% Tween 80. *M. smegmatis* was grown at 37°C or 30°C in Middlebrook 7H9/7H10 or Mueller-Hinton medium. Media were supplemented with 0.5% glycerol plus 0.2% glucose (7H9/7H10 medium only) and 0.05% Tween 80 (all media). For all mycobacteria, the antibiotics kanamycin (20 µg/mL) and hygromycin B (50 µg/mL) were added as needed. *E. coli* strains were grown at 37°C in Miller LB broth or on Miller LB agar. The antibiotics kanamycin (40 µg/mL) and hygromycin B (150 µg/mL) were added as needed.

*M. smegmatis* growth was monitored using resazurin. At an OD~600\ nm~ of 1, cells were diluted to 10^5^ c.f.u. ml^−1^ in the same medium and 100 µl were added to 96-well plates. After 24 hr of growth at 37°C, resazurin (12.5 µg ml−one final concentration; Sigma-Aldrich, St. Louis, MO) was added and fluorescence with excitation at 530 nm and emission at 590 nm was monitored over time. *M. tuberculosis* growth was monitored by measuring the optical density (OD600) of liquid broth cultures over time.

Suppressor collection and sequencing {#s4-2}
------------------------------------

The suppressor screen was performed as described previously ([@bib27]). Suppressors of the *secA2 K129R* allele were isolated by plating independently grown cultures of the *secA2 K129R* strain onto Mueller-Hinton agar at 37°C. Genomic DNA from six suppressors was submitted for whole genome sequencing at the High-Throughput Sequencing Facility at the University of North Carolina at Chapel Hill. Sequencing was performed using Illumina GA II technology. Reads were aligned to the *M. smegmatis* mc^2^155 reference genome (NCBI RefSeq accession number NC_008596.1) using SOAP ([@bib26]).

*M. smegmatis* mutant construction {#s4-3}
----------------------------------

The *M. smegmatis* unmarked ∆*secA2/*∆*satS* double mutant was created by two-step allelic exchange using plasmid pLL50 in the ∆*secA2* mutant strain NR116, resulting in strain BAF1. Briefly, the suicide plasmid pLL50, containing a hygromycin-resistance selectable marker, a *sacB* counter-selectable marker, and flanking regions for *satS* was transformed into *M. smegmatis*. Transformants were selected by plating on media containing hygromycin B. Hygromycin-resistant transformants were grown to saturation, diluted 1:100 in media lacking hygromycin B, and then grown overnight at 37°C. Bacteria in which a second recombination event occurred were selected by plating on 7H10 supplemented with 0.2% glucose and 4.5% sucrose. BAF1 was assessed for the desired chromosomal deletion by PCR and Southern blot.

The *M. smegmatis* unmarked ∆*satS* single mutant was created by adding back *secA2* into the BAF1 strain by two-step allelic exchange using plasmid pBM11, resulting in strain BM10. BM10 was assessed for the desired chromosomal insertion by PCR and Southern blot. Additionally, immunoblots of SecA2 were performed to ensure SecA2 levels were fully restored.

*M. tuberculosis* mutant construction {#s4-4}
-------------------------------------

The *satS* deletion mutant was created in H37Rv using the specialized transducing phage system as previously described ([@bib8]). Briefly, cosmid pSM42 was created by subcloning *satS* upstream and downstream flanks into pYUB854 surrounding the hygromycin cassette. Cosmid pSM42 was ligated into phAE159 to generate recombinant phasmid pSM45. The recombinant phasmid, pSM45 was packaged into phage head using a λ in vitro packaging extract kit (Gigapack III XL, Agilent, Santa Clara, CA) and was transduced into *E. coli*. Phasmid DNA was electroporated into *M. smegmatis* mc^2^155 to make phage (pSM60). Transduced phage was plaque purified and amplified for high titer phage lysate. H37Rv was transduced with high phage lysate as previously described ([@bib8]). Transductants were grown at 37°C on Middlebrook 7H10 plates containing hygromycin for 4 weeks. To confirm the *satS* deletion in transductants, PCR and Southern blotting were used.

Azide sensitivity assays {#s4-5}
------------------------

Cultures were plated for azide sensitivity as previously described, by mixing 200 μL of a saturated culture with 7H9 top agar and pouring over 7H10 agar plates lacking tween in three technical replicates ([@bib27]). The diameter of the zone of inhibition was measured after two days and reported as a percentage of the entire plate diameter, yielding percent azide inhibition.

Subcellular fractionation and immunoblotting {#s4-6}
--------------------------------------------

When whole cell lysates were prepared from the same cultures used to isolate culture filtrate proteins, exponential phase *M. tuberculosis* cultures grown in Sauton media without detergent were fixed in an equal volume of 10% formalin for 1 hr. Fixed cells were pelleted by centrifugation, resuspended in extraction buffer, and lysed by bead beating.

When prepared for subcellular fractionation, cultures of *M. smegmatis* and irradiated *M. tuberculosis* grown in Middlebrook 7H9 medium were isolated as previously described ([@bib34]; [@bib16]). Briefly, cells suspended in 1X PBS containing protease inhibitors were lysed by passage through a French pressure cell. Unlysed cells were removed by centrifugation at 3000 x *g* for 30 min to generate clarified whole cell lysates (WCLs). The WCLs were either spun at 100,000 x g for 2 hr to collect the cell envelope fraction containing both the cell wall and membrane (ENV) or at 27,000 x *g* for 30 min to pellet the cell wall fraction only (CW). The supernatant following CW isolation was spun at 100,000 x *g* for 2 hr to separate the membrane fraction (MEM) and collect the soluble cytoplasm-containing fraction (SOL). Protein concentrations were determined by bicinchoninic acid assay (Pierce, ThermoFisher, Waltham, MA).

Samples containing equal protein were separated by SDS-PAGE and transferred to nitrocellulose membranes. After blocking, proteins were detected using antibodies described in the Key Resources Table.αHis (Abgent, San Diego, CA) was used to detect the mycobacterial GroEL1 which has a string of endogenous histidines. αMouse and αRabbit IgG conjugated horseradish peroxidase secondary antibodies (Bio-Rad, Hercules, CA) were used and signal was detected using Western Lightning Plus-ECL chemiluminescent detection reagent (Perkin-Elmer, Waltham, MA).

Culture filtrate protein preparation {#s4-7}
------------------------------------

M.*M. tuberculosis* culture filtrates were collected as described previously ([@bib57]). Briefly, 200 mL cultures were grown in Sauton media at 37°C for 24 hr. The supernatants were double filtered through a 0.2 µm filter. Supernatant proteins were concentrated 200 fold using 3,000 MW cut off centrifuge filters (Amicon) by centrifugation at 3,000 rpm at 4°C. For immunoblotting, protein was precipitated overnight at 4°C with 10% trichloroethanoic acid (TCA). Protein pellets were washed with acetone, resuspended in 250 uL of 1 x SDS-PAGE buffer.

For *M. smegmatis* culture filtrate collection, samples were obtained as previously described ([@bib16]). In brief, 10 mL cultures were grown without Tween 80 to an OD~600\ nm~ of 0.4 to 0.7. Supernatant was separated from cells first by centrifugation at 3000 x g and then filtration through a 0.2-μm-pore-size filter. Protein from 2 mL of supernatant was TCA precipitated as described above and then resuspended in 50 μL of 1 × SDS PAGE buffer.

Phosphatase activity assay {#s4-8}
--------------------------

SapM activity was assayed as described previously ([@bib41]; [@bib57]). In a 96 well plate, 3 µg of CFP protein was diluted with water and added to 10X buffer (1M Tris base pH 6.8) with 20 mM Sodium tartrate to reduce background phosphatase activity, and 50 mM p-nitrophenyl phosphate (pNPP) for a total volume of 200 µL (New England Biolabs, Ipswich, MA). Tartrate is an inhibitor of some phosphatases, but SapM activity is unaffected by tartrate ([@bib41]). Despite the addition of tartrate, the phosphatase assay used is not specific for SapM. The residual activity in the ∆*secA2* and ∆*satS* mutants can be attributed to SatS-independent phosphatases. The plate was incubated at 37°C in a plate reader, and the absorbance at 405 nm was measured every three minutes for four hours. Over the linear portion of the kinetic assay, we calculated the rate of pNPP conversion by calculating the slope of the line generated by plotting Abs~405\ nm~ as a function of time. These slopes were then normalized to the WT rate of change, which we set to 100%.

Whole cell phosphatase activity assay {#s4-9}
-------------------------------------

To perform the whole cell phosphatase activity assay, *M. smegmatis* strains expressing SapM (±ss) or an empty vector were grown in 7H9 medium to an OD~600~ of 1, pelleted, and washed once in 7H9 medium. Cells were diluted to 6.25 × 10^5^ CFU/mL in 7H9 medium and 160 μL was added in triplicate to a 96-well plate. Plates were incubated at 37°C for 24 hr. After 24 hr, 20 μL of 10X buffer (1M Tris base pH 6.8) with 20 mM Sodium tartrate and 50 mM p-nitrophenyl phosphate (pNPP) were added to the wells for a total volume of 200 µL. The plate was incubated at 37°C in a plate reader, and the absorbance at 405 nm was measured every three minutes for four hours. We calculated the rate of pNPP conversion as described above.

Macrophage infection {#s4-10}
--------------------

To assess *M. tuberculosis* survival in macrophages, 2 × 10^5^ BMDMs from C57BL/6 mice were seeded 1 day prior to infection with *M. tuberculosis* (H37Rv, ∆*secA2*, ∆*satS*, or ∆*satS +psatS*) at an MOI of 1 as previously described ([@bib45]; [@bib57]). At 4 hr post infection, macrophages were washed four times and at the indicated time points were lysed with 0.1% Triton X-100. Serial dilutions of the lysates were plated on 7H11 agar plates and CFUs were counted three weeks later.

Reverse transcriptase-PCR {#s4-11}
-------------------------

To assess the operon nature of *sapM* and *satS*, RNA was extracted from mid-log phase cultures of *M. tuberculosis* H37Rv (see *qRT-PCR* for Materials and methods). Reverse transcription reaction was carried out using iScript cDNA Synthesis Kit (Bio-Rad) and random primers. PCR amplification of the intergenic regions on cDNA were performed using specific primers on *sapM* and *satS* (Key Resources Table). Controls included primers for the housekeeping gene *sigA*, PCR amplification from genomic DNA, and PCR amplification from RNA lacking reverse transcriptase.

Quantitative Real-Time PCR {#s4-12}
--------------------------

Triplicate *M. tuberculosis* cultures were grown in modified 7H9 medium to an OD~600~ of 1 and RNA was isolated as previously described using a chloroform-methanol and Trizol (Invitrogen) extraction ([@bib34]; [@bib17]). RNA samples were treated with DNase (Promega, Madison, WI) and then column purified (Zymo RNA clean and concentrator Kit, Irvine, CA). Following RNA isolation, cDNA was synthesized with random primers using the iScript cDNA Synthesis Kit (Bio-Rad). Real-time PCR was completed using 25 ng of cDNA template in triplicate technical replicates using the SensiMix SYBR and fluorescein kit (Bioline, Toronto, Canada). Transcripts were normalized to the housekeeping gene *sigA*. Primer sequences are provided in the Key Resources Table.

LacZ (β-galactosidase) activity assays {#s4-13}
--------------------------------------

LacZ activity assays in *M. tuberculosis* were performed using a modified protocol previously described for *M. smegmatis* ([@bib27]). Strains were grown in 7AGT to mid-log phase and 800 μL was pelleted. Pellets were resuspend in 800 μL Z buffer (60 mM Na~2~HPO~4~, 40 mM NaH~2~PO~4~, 10 mM KCl, 1 mM MgSO~4~, 50 mM β-mercaptoethanol), then lysed with 35 μL chloroform and 1 μL of 0.1% SDS by vortexing for 30 s followed by sonication. 640 µg of *o*-nitrophenyl-β-D-galatopyranoside was added to each reaction and mixtures were incubated for 24 min at room temperature. Reactions were terminated by addition of 400 μL of 1 M Na~2~CO~3~. Debris was removed by centrifugation at 3,000 rpm for 10 min, and the OD~420\ nm~ was read from the supernatant. LacZ activity (Miller units) was calculated by the following formula: (1000 x OD~420\ nm~)/(\[reaction time in minutes\] x \[culture volume used in the reaction, in mL\] x OD~600\ nm~).

SatS antiserum production {#s4-14}
-------------------------

To generate polyclonal antisera against SatS, purified SatS*~Mtb~* was produced in *E. coli* and injected into two rabbits using Titermax adjuvant (ThermoFisher). The serum from both rabbits was tested against wild-type *M. tuberculosis* and *M. smegmatis* and the ∆*satS* mutants for specificity. The serum from rabbit PA6753 recognizes SatS*~Mtb~* but does not recognize SatS*~Msm~* and is only used for SatS*~Mtb~*. The sera from rabbit PA6754 has a non-specific band at the same size as SatS*~Mtb~*, but recognizes SatS*~Msm~* and is only used for SatS*~Msm~*.

Co-immunoprecipitation {#s4-15}
----------------------

For in vivo co-immunoprecipitation, *M. smegmatis* cells were transformed with SatS*~Mtb~* (±HA) tag and SapM-FLAG (±signal sequence). Transformed cells were grown in 50 mL of 7H9 medium to an OD~600\ nm~ of 0.5. Cells were pelleted and resuspended in 2.5 mL 1X PBS buffer containing a protease inhibitor cocktail. Cells were lysed by passage through a French pressure cell. Unlysed cells were removed by centrifugation at 3000 x *g* for 30 min to generate clarified whole cell lysates (WCLs). 200 μL of lysate was diluted in 1 mL of 1X PBS + protease inhibitors, added to 25 μL anti-HA agarose (Sigma-Aldrich), and mixed end to end at 4°C for 4 hr, followed by four washes with 1X PBS. The immunoprecipitated SatS-HA along with co-immunoprecipitated proteins were eluted in 25 μL of 1X SDS-PAGE buffer, run on 15% SDS-PAGE gels for 4.5 hr, transferred onto nitrocellulose membranes, and immunoblotted.

Cloning, expression, and purification of SapM inclusion bodies (IBs) {#s4-16}
--------------------------------------------------------------------

The *sapM* full length gene was PCR amplified from genomic DNA of H37Rv using Phusion high-fidelity DNA polymerase and the primers sapM *E. coli* F and sapM *E. coli* R. The resulting PCR product treated with T4 polymerase and mixed with linear, T4 treated, pMSCG-28 vector, and transformed into chemically competent BL21 (DE3) cells as previously described ([@bib15]).

SapM containing a C-His~6~-tag and tobacco etch virus (TEV) protease cleavage site were grown in Luria-Bertani (LB) broth containing 100 µg/mL carbenicillin at 37°C to an OD of 0.8 (A~600\ nm~). SapM expression was induced with the addition of 0.5 mM isopropyl-β-D-thiogalactoside (IPTG) and cells were grown for an additional 5 hr at 37°C. Cells were harvested and resuspended in lysis buffer (40 mM HEPES pH 7.4, 300 mM NaCl, 10 mM imidazole). Cells were broken using a high-pressure homogenizer in the presence of protease inhibitor cocktail (EMD Millipore, Burlington, MA) and centrifuged at 30,000 x *g*.

In order to clarify SapM IBs, a modified protocol was adopted ([@bib32]). The supernatant obtained after cell lysis was decanted and the pellet resuspended in 40 mM HEPES pH 7.4, 2% Triton X-100, 5 mM EDTA. The suspension was then homogenized using sonication for 3 cycles for 30 s each, centrifuged at 30,000 x *g* for 15 min, and the supernatant decanted. This was repeated three times to remove cell wall, membrane material, and lipid/membrane associated proteins. In the final step, detergent was omitted, and SapM purity of greater than 95% was confirmed via SDS-PAGE.

Protein aggregation assay {#s4-17}
-------------------------

Inclusion bodies of SapM pre protein with a 6X C-terminal His tag were denatured in 8 M urea, 40 mM HEPES pH 7.4, 100 mM NaCl, 1 mM EDTA to a final concentration of 150 µM. Denatured SapM (1 µL) was rapidly diluted into buffer (150 µL) containing 40 mM HEPES pH 7.4, 100 mM NaCl, and 1 mM EDTA. Protein aggregation was monitored in the absence or presence of SatS at 25°C by measuring light scattering in a time dependent manner using a Cary Eclipse Varian with excitation and emission at 350 nm.

Cloning, expression, purification, and crystallization of SatS and SatS~C~ {#s4-18}
--------------------------------------------------------------------------

The *satS* and *satS~C~* genes were PCR amplified from genomic DNA of H37Rv using Phusion high-fidelity DNA polymerase and the primers *satS E. coli* F, *satS~C~ E. coli* F, and *satS/satS~C~ E. coli* R. The resulting PCR products were digested with NdeI and HindIII, ligated into Nde/HindIII digested Pet28b vector, and transformed into chemically competent BL21 (DE3) cells.

SatS and SatS~C~ with a N-His~6~-tag and TEV protease cleavage site were grown separately in LB broth containing 50 µg/mL kanamycin at 37°C to an OD of 0.8 (A~600\ nm~). SatS and SatS~C~ expression was induced with the addition of 0.5 mM IPTG and cells were grown for an additional 5 hr at 37°C. Cells were harvested and resuspended in lysis buffer (40 mM HEPES pH 7.4, 300 mM NaCl, 10 mM imidazole). Cells were broken using a high-pressure homogenizer in the presence of protease inhibitor cocktail (EMD Millipore) and centrifuged at 30,000 x *g*. SatS and SatS~C~ were purified using a cOmplete His-tag purification resin (Roche, Basel, Switzerland), followed by removal of the tag using TEV protease at 25°C and further purified by size exclusion chromatography using a Superdex 200 26/60 (GE Healthcare, Chicago, IL). Protein purity was greater than 95% as determined by SDS-PAGE. Protein concentration was measured spectrophotometrically at 595 nm using Bradford reagent.

Crystals of SatS (20 mg/mL) were produced after screening 768 individual conditions using sitting drop vapor diffusion method at 16°C with a 50 µL well solution and a drop consisting of 1.2 µL of 0.6 µL protein and 0.6 µL of well solution. A single diffraction quality crystal appeared within 6 months in 3.5 M ammonium sulfate and 0.1 M sodium acetate trihydrate pH 4.6. SatS was indexed into space group P2~1~2~1~2~1~ with the unit cell parameters a = 50, b = 51, c = 76. The unit cell was comprised of a single molecule in the asymmetric unit.

Crystals of SatS~C~ (12 mg/mL) were produced after screening 384 individual conditions using sitting drop vapor diffusion method at 16°C with a 50 µL well solution and a drop consisting of 1.2 µL of 0.6 µL protein and 0.6 µL of well solution. Initial crystal hits were optimized using hanging drop vapor diffusion method at 16°C with a 1 mL well solution and a 4.0 µL drop consisting of random ratios of protein to well solution. The highest quality crystals appeared overnight in 3.5 M ammonium citrate pH 6.4 and continued to mature for an additional 2 weeks. SatS~C~ indexed into space group P2~1~2~1~2~1~ with the unit cell parameters a = 50, b = 51, c = 76. The unit cell was comprised of a single molecule in the asymmetric unit.

Data collection and structure determination of SatS~C~ {#s4-19}
------------------------------------------------------

X-ray diffraction data were collected from a single crystal at beamline 23-ID of the GM/CA-CAT facilities of the Advanced Photon Source, Argonne National Laboratory. The structure of SatS was solved by single-wavelength anomalous dispersion (SAD) using a Bromine (Br) derivative. The data were processed and reduced using the HKL3000 software package. A single Br site was identified using Phenix HySS, and Phenix AutoSol was used to produce the initial electron density map. Simultaneous rounds of model building and structure refinement were performed manually in Coot and Phenix Refine. Additional structures of SatS~C~ were solved by molecular replacement using the initial structure of SatS~C~ as a model in Phenix Phaser MR. Simultaneous rounds of model building and structure refinement were carried out in Coot and Phenix Refine.

Statistical analyses {#s4-20}
--------------------

For comparisons between the groups for the determination of (i) phosphatase activity in the mycobacterial culture filtrates, (ii) whole cell phosphatase activity (iii) '*lacZ* reporter fusions and (iv) growth in macrophages, one-way analysis of variance (ANOVA) with the Tukey post test was employed. For the statistical analysis and generation of graphs, Prism five software (version 7; GraphPad Software Inc., CA) was used.
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HughesRCSacchettiniJC2019The crystal structure of SatS c-terminal domain in complex with bromineProtein Data Bank6DRQ

HughesRC2019The crystal structure of SatS c-terminal domainProtein Data Bank6DNM

The following previously published dataset was used:

DekkerCdeKruijff BGrosP2003Crystal Structure of SecB from Escherichia coliProtein Data Bank1QYN

10.7554/eLife.40063.027

Decision letter

Kana

Bavesh D

Reviewing Editor

University of the Witwatersrand

South Africa

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*Mycobacterium tuberculosis* SatS is a chaperone for the SecA2 protein export pathway\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Gisela Storz as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The submission by Braunstein and colleagues describes an investigation of secretion through the specialized SecA2 translocation system in mycobacteria. Using a mutant with a K129R mutation in SecA2, the authors isolate suppressors of the growth defect in this strain that mapped to Msmeg_1684, with mutations in various regions of this gene. The authors annotate this gene as SatS and confirm that deletion thereof relieved defects of the *secA2 K129R* mutant. Using heterologous complementation experiments, the authors also confirm that the SatS proteins from *M. tuberculosis* and *M. smegmatis* are functionally interchangeable. Loss of SatS was able to correct mis-localization of the SecA2 K129R mutant protein, which was found predominantly in the soluble fraction in the SatS deletion mutant. Deletion of *satS* alleviated the SecY abundance defects in the SecA2 K129R mutant. Next, the authors delete *satS* in *M. tuberculosis* and report a dramatic reduction in SapM secretion and, as SapM has phosphatase activity, reduced phosphatase activity in the culture filtrate of the mutant. Similar results were noted when the *M. tuberculosis* SapM was expressed in *M. smegmatis.* Following this, the authors confirm that Mce1, Mce1E and Mce4A-HA (but not PknG, PhoS1 or Msmeg1704-HA) required SatS for transport. The authors note that deletion of SatS resulted in reduced cytoplasmic levels of some proposed targets, suggesting that SatS post-translationally stabalizes its targets, possibly serving as an export chaperone. This hypothesis was supported by the demonstration that SatS co-precipitates with one of its targets, SapM; this interaction was not dependent on the signal sequence of SapM. Using a *satS secA2* double mutant, the authors confirm that SatS most likely stabilizes substrates before they are transported by the SecA2 translocon. With recombinant forms of SatS and SapM, the authors confirm that SatS prevented aggregation of SapM, much like a chaperone acting on its natural substrate. Structural analysis of the SatS C-terminal domain suggested a novel fold, with an electronegative charge, similar to other reported chaperones. Consistent with this, the C-terminal domain was sufficient to prevent aggregation of recombinant SapM. The authors further interrogate the role of the G143 residue in SatS and their observations suggest that SatS has more than one role in secretion of a select set of SecA2 substrates.

Key findings:

1\) Deletion of SatS relieves growth defects of a SatS defective mutant and affects secretion of SapM;

2\) Mce1, Mce1E and Mce4A-HA require SatS for transport;

3\) SatS is able to associate with target proteins such as SapM and cause disaggregation in manner akin to chaperones;

4\) Structural analysis of the SatS C-terminus revealed a hydrophobic core, much like other known secretion chaperones, despite having a more unique overall structure;

5\) Collective findings identify SatS as a chaperone in mycobacteria that is able to associate with and stabilize its targets for secretion.

Essential revisions:

1\) As a general comment, ensure that appropriate loading controls are included in all western blots. Also, quantification of all blots would provide a numeric value of secretion and allow for statistics. This should be done. The *sapM* mutant analysis of cell associated and secreted proteins should be combined into one figure. The loading controls in Figure 2 are irrelevant if there isn\'t a positive control. Later in Figure 4 the authors show the cell-associated proteins; all of these data should be combined from a single experiment (i.e., with the same cultures), examining cell associated and secreted proteins along with loading controls.

2\) \"Virulence\" really can\'t be measured in an ex vivo macrophage assay and in the absence of in vivo data, refrain from using this term. The only conclusion that can be made is that bacterial growth is affected. Also, are all of the strains plasmid-transformed i.e. the wild type and mutant strains should have empty vectors to rule out plasmid effects for all of the reported assays, but in particular for the macrophage work? These controls must be included.

3\) The authors neglect the SecA1 system in their interpretations throughout the manuscript. It appears that SatS could also be a chaperone for the SecA1 system and the substrates of SecA2, that the authors focused on, could also be substrates of SecA1. As the *satS* null strain is more defective than the *secA2* null strain in SapM and Mce secretion (Figure 2), does this mean that SatS functions as a chaperone for both SecA1 and SecA2 systems and SapM and Mce proteins are secreted by both? In the third paragraph of the subsection "SatS as a protein export chaperone", the authors state that the lower protein levels of the substrates in the *satS* mutant compared to the *secA2* mutant explains why the *satS* mutant secretion defect was more dramatic than that of the *secA2* mutant. But if the substrates depend on the SecA2 system for secretion, shouldn\'t they not be secreted at all in the null? More careful exposition of these findings and appending conclusions would be useful.

4\) The models proposed in the Discussion are not supported by the data presented. The authors argue against a role for SatS in general SecA2 functioning because they don\'t observe an effect of the *satS* null mutant on all SecA2 substrates. Instead, the authors favour a model where in order for SecA2 to be delivered or engage the SecYEG channel, it must first be bound to a substrate and SatS functions as a protein export chaperone that facilitates this SecA2-substrate interaction. If this is true, why can\'t the SatS-independent SecA2 substrates cause accumulation of the SecA2 K129R mutant in the membrane in the absence of SatS? Another possibility is that as a chaperone, SatS increases the protein stability of the SecA2 K129R mutant and the *satS* null results in an unstable SecA2 K129R protein that does not interfere with SecA1 system. The authors should show the western blots used to make the calculations in Figure 1D, which may address this possibility. This potential function of SatS may or may not be relevant when WT SecA2 is expressed. It is possible that the K129R mutation is causing the protein to be unfolded and targeting it to SatS.

5\) Why doesn\'t complemented SatS mutant look like H37Rv in Figure 2A?

10.7554/eLife.40063.028

Author response

> Essential revisions:
>
> 1\) As a general comment, ensure that appropriate loading controls are included in all western blots. Also, quantification of all blots would provide a numeric value of secretion and allow for statistics. This should be done. The sapM mutant analysis of cell associated and secreted proteins should be combined into one figure. The loading controls in Figure 2 are irrelevant if there isn\'t a positive control. Later in Figure 4 the authors show the cell-associated proteins; all of these data should be combined from a single experiment (i.e., with the same cultures), examining cell associated and secreted proteins along with loading controls.

We addressed these comments with the following actions:

-- We quantified all of our immunoblots for monitoring secretion as requested (Figures 2, 3, 6 and 9) from triplicate experiments. Quantitated mean values and statistical significance compared to the wild type strain are now provided in these figures (mean values and asterisk indicating significance are provided under a representative blot).

-- To address the missing loading control, which was a loading control for secreted proteins of *M. smegmatis*, we added an immunoblot for the secreted Mpt32 protein to Figures 2, 6, and 9. To immunoblots for ruling out cell lysis contamination of secreted culture filtrate proteins (CFP) we added positive controls (Figure 2---figure supplement 3).

-- We remade CFP and whole cell lysates from the same cultures for Figure 2. These new data are presented Figure 2A and 2E for *M. tuberculosis* and Figure 2C and 2G for *M. smegmatis*. Importantly, the results are identical to what we presented previously.

-- We rearranged the presentation of the Results to allow for secreted and cell associated protein analysis to be discussed together. This change required reorganizing text and Figures 2, 3, and 4.

> 2\) \"Virulence\" really can\'t be measured in an ex vivo macrophage assay and in the absence of in vivo data, refrain from using this term. The only conclusion that can be made is that bacterial growth is affected. Also, are all of the strains plasmid-transformed i.e. the wild type and mutant strains should have empty vectors to rule out plasmid effects for all of the reported assays, but in particular for the macrophage work? These controls must be included.

We addressed these comments with the following actions:

-- We replaced the term virulence and now more precisely describe the results as demonstrating that SatS is required for growth in macrophages.

-- In all experiments, wild type and mutant strains carry empty vectors. A sentence was added to the Materials and methods clarifying this point. For the macrophage experiments, we modified the figure to indicate the presence of empty vectors in wild type and mutant strains.

> 3\) The authors neglect the SecA1 system in their interpretations throughout the manuscript. It appears that SatS could also be a chaperone for the SecA1 system and the substrates of SecA2, that the authors focused on, could also be substrates of SecA1. As the satS null strain is more defective than the secA2 null strain in SapM and Mce secretion (Figure 2), does this mean that SatS functions as a chaperone for both SecA1 and SecA2 systems and SapM and Mce proteins are secreted by both? In the third paragraph of the subsection "SatS as a protein export chaperone", the authors state that the lower protein levels of the substrates in the satS mutant compared to the secA2 mutant explains why the satS mutant secretion defect was more dramatic than that of the secA2 mutant. But if the substrates depend on the SecA2 system for secretion, shouldn\'t they not be secreted at all in the null? More careful exposition of these findings and appending conclusions would be useful.

We apologize for not clearly addressing the partial nature of *secA2* mutant export defects and for not discussing before the possibility of SatS also working with SecA1 and the general Sec pathway. A consistent finding in all published studies of *secA2* mutants across three mycobacterial species is that the export defects of *secA2* mutants is never 100% (i.e. in the absence of SecA2 some residual export occurs) (Braunstein et al., 2001; van der Woude et al., 2014; Feltcher et al., 2015; Zulauf et al., 2018). Although the pathway responsible for the residual export in a *secA2* mutant is unknown, SecA1/the general Sec pathway is the likely candidate. Thus, SatS may also work with SecA1. Furthermore, with our studies so far, we cannot rule out the possibility of there being substrates of SatS that are completely SecA2-independent. We modified the Discussion to cover these details.

> 4\) The models proposed in the Discussion are not supported by the data presented. The authors argue against a role for SatS in general SecA2 functioning because they don\'t observe an effect of the satS null mutant on all SecA2 substrates. Instead, the authors favour a model where in order for SecA2 to be delivered or engage the SecYEG channel, it must first be bound to a substrate and SatS functions as a protein export chaperone that facilitates this SecA2-substrate interaction. If this is true, why can\'t the SatS-independent SecA2 substrates cause accumulation of the SecA2 K129R mutant in the membrane in the absence of SatS? Another possibility is that as a chaperone, SatS increases the protein stability of the SecA2 K129R mutant and the satS null results in an unstable SecA2 K129R protein that does not interfere with SecA1 system. The authors should show the western blots used to make the calculations in Figure 1D, which may address this possibility. This potential function of SatS may or may not be relevant when WT SecA2 is expressed. It is possible that the K129R mutation is causing the protein to be unfolded and targeting it to SatS.

We addressed the comments with the following actions:

-- The reviewers raise a good point about our model for suppression by loss of *satS*. This question about our model is now addressed in the Discussion. We suspect the reason deleting *satS* is sufficient to suppress *secA2 K129R* phenotypes is that the threshold for phenotypic suppression does not require all SecA2 K129R to be diverted from the SecYEG channel.

-- In response to the possibility raised of SatS increasing the protein stability of SecA2 K129R, we added the requested representative immunoblot to Figure 1D. This immunoblot demonstrated that SecA2 K129R levels are not affected by the presence or absence of SatS, which argues against this proposal for SatS acting as a chaperone that stabilizes SecA2 K129R. We also added text to the Results section indicating that the level of SecA2 K129R level was unchanged in a *satS* mutant.

> 5\) Why doesn\'t complemented SatS mutant look like H37Rv in Figure 2A?

Our SatS complementing plasmid used in *M. tuberculosis* only restored SatS levels to 26% of wild type levels, which likely accounts for the partial complementation observed. We added this SatS immunoblot data in Figure 2---figure supplement 3A and we now note the partial complementation in the Results section.
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